,text,tags,ori_tags
0,Clustering of missense mutations in the ataxia - telangiectasia gene in a sporadic T - cell leukaemia .,Clustering of missense mutations in the   [ ataxia - telangiectasia | Disease ] gene in a     [ sporadic T - cell leukaemia | Disease ]. ,O O O O O O B-Disease I-Disease I-Disease O O O B-Disease I-Disease I-Disease I-Disease I-Disease O 
1,Ataxia - telangiectasia ( A - T ) is a recessive multi - system disorder caused by mutations in the ATM gene at 11q22 - q23 ( ref . 3 ) .,  [ Ataxia - telangiectasia | Disease ] (   [ A - T | Disease ] ) is a     [ recessive multi - system disorder | Disease ] caused by mutations in the ATM gene at 11q22 - q23 ( ref. 3 ). ,B-Disease I-Disease I-Disease O B-Disease I-Disease I-Disease O O O B-Disease I-Disease I-Disease I-Disease I-Disease O O O O O O O O O O O O O O O O O 
2,"The risk of cancer , especially lymphoid neoplasias , is substantially elevated in A - T patients and has long been associated with chromosomal instability .","The risk of [ cancer | Disease ], especially  [ lymphoid neoplasias | Disease ], is substantially elevated in   [ A - T | Disease ] patients and has long been associated with chromosomal instability. ",O O O B-Disease O O B-Disease I-Disease O O O O O B-Disease I-Disease I-Disease O O O O O O O O O O 
3,"By analysing tumour DNA from patients with sporadic T - cell prolymphocytic leukaemia ( T - PLL ) , a rare clonal malignancy with similarities to a mature T - cell leukaemia seen in A - T , we demonstrate a high frequency of ATM mutations in T - PLL .","By analysing [ tumour | Disease ] DNA from patients with      [ sporadic T - cell prolymphocytic leukaemia | Disease ] (   [ T - PLL | Disease ] ), a rare  [ clonal malignancy | Disease ] with similarities to a     [ mature T - cell leukaemia | Disease ] seen in   [ A - T | Disease ], we demonstrate a high frequency of ATM mutations in   [ T - PLL | Disease ]. ",O O B-Disease O O O O B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O B-Disease I-Disease I-Disease O O O O B-Disease I-Disease O O O O B-Disease I-Disease I-Disease I-Disease I-Disease O O B-Disease I-Disease I-Disease O O O O O O O O O O B-Disease I-Disease I-Disease O 
4,"In marked contrast to the ATM mutation pattern in A - T , the most frequent nucleotide changes in this leukaemia were missense mutations .","In marked contrast to the ATM mutation pattern in   [ A - T | Disease ], the most frequent nucleotide changes in this [ leukaemia | Disease ] were missense mutations. ",O O O O O O O O O B-Disease I-Disease I-Disease O O O O O O O O B-Disease O O O O 
5,"These clustered in the region corresponding to the kinase domain , which is highly conserved in ATM - related proteins in mouse , yeast and Drosophila .","These clustered in the region corresponding to the kinase domain, which is highly conserved in ATM - related proteins in mouse, yeast and Drosophila. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O 
6,The resulting amino - acid substitutions are predicted to interfere with ATP binding or substrate recognition .,The resulting amino - acid substitutions are predicted to interfere with ATP binding or substrate recognition. ,O O O O O O O O O O O O O O O O O 
7,Two of seventeen mutated T - PLL samples had a previously reported A - T allele .,Two of seventeen mutated   [ T - PLL | Disease ] samples had a previously reported   [ A - T | Disease ] allele. ,O O O O B-Disease I-Disease I-Disease O O O O O B-Disease I-Disease I-Disease O O 
8,"In contrast , no mutations were detected in the p53 gene , suggesting that this tumour suppressor is not frequently altered in this leukaemia .","In contrast, no mutations were detected in the p53 gene, suggesting that this [ tumour | Disease ] suppressor is not frequently altered in this [ leukaemia | Disease ]. ",O O O O O O O O O O O O O O O B-Disease O O O O O O O B-Disease O 
9,Occasional missense mutations in ATM were also found in tumour DNA from patients with B - cell non - Hodgkins lymphomas ( B - NHL ) and a B - NHL cell line .,Occasional missense mutations in ATM were also found in [ tumour | Disease ] DNA from patients with       [ B - cell non - Hodgkins lymphomas | Disease ] (   [ B - NHL | Disease ] ) and a   [ B - NHL | Disease ] cell line. ,O O O O O O O O O B-Disease O O O O B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O B-Disease I-Disease I-Disease O O O B-Disease I-Disease I-Disease O O O 
10,The evidence of a significant proportion of loss - of - function mutations and a complete absence of the normal copy of ATM in the majority of mutated tumours establishes somatic inactivation of this gene in the pathogenesis of sporadic T - PLL and suggests that ATM acts as a tumour suppressor .,The evidence of a significant proportion of loss - of - function mutations and a complete absence of the normal copy of ATM in the majority of mutated [ tumours | Disease ] establishes somatic inactivation of this gene in the pathogenesis of    [ sporadic T - PLL | Disease ] and suggests that ATM acts as a [ tumour | Disease ] suppressor. ,O O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease O O O O O O O B-Disease O O 
11,"As constitutional DNA was not available , a putative hereditary predisposition to T - PLL will require further investigation . .","As constitutional DNA was not available, a putative hereditary predisposition to   [ T - PLL | Disease ] will require further investigation.. ",O O O O O O O O O O O O B-Disease I-Disease I-Disease O O O O O O 
12,Myotonic dystrophy protein kinase is involved in the modulation of the Ca2 + homeostasis in skeletal muscle cells ., [ Myotonic dystrophy | Disease ] protein kinase is involved in the modulation of the Ca2 + homeostasis in skeletal muscle cells. ,B-Disease I-Disease O O O O O O O O O O O O O O O O O 
13,"Myotonic dystrophy ( DM ) , the most prevalent muscular disorder in adults , is caused by ( CTG ) n - repeat expansion in a gene encoding a protein kinase ( DM protein kinase ; DMPK ) and involves changes in cytoarchitecture and ion homeostasis ."," [ Myotonic dystrophy | Disease ] ( [ DM | Disease ] ), the most prevalent  [ muscular disorder | Disease ] in adults, is caused by ( CTG ) n - repeat expansion in a gene encoding a protein kinase ( [ DM | Disease ] protein kinase ; DMPK ) and involves changes in cytoarchitecture and ion homeostasis. ",B-Disease I-Disease O B-Disease O O O O O B-Disease I-Disease O O O O O O O O O O O O O O O O O O O O O B-Disease O O O O O O O O O O O O O O 
14,"To obtain clues to the normal biological role of DMPK in cellular ion homeostasis , we have compared the resting [ Ca2 + ] i , the amplitude and shape of depolarization - induced Ca2 + transients , and the content of ATP - driven ion pumps in cultured skeletal muscle cells of wild - type and DMPK [ - / - ] knockout mice .","To obtain clues to the normal biological role of DMPK in cellular ion homeostasis, we have compared the resting [ Ca2 + ] i, the amplitude and shape of depolarization - induced Ca2 + transients, and the content of ATP - driven ion pumps in cultured skeletal muscle cells of wild - type and DMPK [ - / - ] knockout mice. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
15,In vitro - differentiated DMPK [ - / - ] myotubes exhibit a higher resting [ Ca2 + ] i than do wild - type myotubes because of an altered open probability of voltage - dependent l - type Ca2 + and Na + channels .,In vitro - differentiated DMPK [ - / - ] myotubes exhibit a higher resting [ Ca2 + ] i than do wild - type myotubes because of an altered open probability of voltage - dependent l - type Ca2 + and Na + channels. ,O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
16,The mutant myotubes exhibit smaller and slower Ca2 + responses upon triggering by acetylcholine or high external K + .,The mutant myotubes exhibit smaller and slower Ca2 + responses upon triggering by acetylcholine or high external K +. ,O O O O O O O O O O O O O O O O O O O O 
17,"In addition , we observed that these Ca2 + transients partially result from an influx of extracellular Ca2 + through the l - type Ca2 + channel .","In addition, we observed that these Ca2 + transients partially result from an influx of extracellular Ca2 + through the l - type Ca2 + channel. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
18,Neither the content nor the activity of Na + / K + ATPase and sarcoplasmic reticulum Ca2 + - ATPase are affected by DMPK absence .,Neither the content nor the activity of Na + / K + ATPase and sarcoplasmic reticulum Ca2 + - ATPase are affected by DMPK absence. ,O O O O O O O O O O O O O O O O O O O O O O O O O O 
19,"In conclusion , our data suggest that DMPK is involved in modulating the initial events of excitation - contraction coupling in skeletal muscle . .","In conclusion, our data suggest that DMPK is involved in modulating the initial events of excitation - contraction coupling in skeletal muscle.. ",O O O O O O O O O O O O O O O O O O O O O O O O O 
20,Constitutional RB1 - gene mutations in patients with isolated unilateral retinoblastoma .,Constitutional RB1 - gene mutations in patients with isolated  [ unilateral retinoblastoma | Disease ]. ,O O O O O O O O O B-Disease I-Disease O 
21,"In most patients with isolated unilateral retinoblastoma , tumor development is initiated by somatic inactivation of both alleles of the RB1 gene .","In most patients with isolated  [ unilateral retinoblastoma | Disease ], [ tumor | Disease ] development is initiated by somatic inactivation of both alleles of the RB1 gene. ",O O O O O B-Disease I-Disease O B-Disease O O O O O O O O O O O O O O 
22,"However , some of these patients can transmit retinoblastoma predisposition to their offspring .","However, some of these patients can transmit [ retinoblastoma | Disease ] predisposition to their offspring. ",O O O O O O O O B-Disease O O O O O 
23,"To determine the frequency and nature of constitutional RB1 - gene mutations in patients with isolated unilateral retinoblastoma , we analyzed DNA from peripheral blood and from tumor tissue .","To determine the frequency and nature of constitutional RB1 - gene mutations in patients with isolated  [ unilateral retinoblastoma | Disease ], we analyzed DNA from peripheral blood and from [ tumor | Disease ] tissue. ",O O O O O O O O O O O O O O O O B-Disease I-Disease O O O O O O O O O B-Disease O O 
24,The analysis of tumors from 54 ( 71 % ) of 76 informative patients showed loss of constitutional heterozygosity ( LOH ) at intragenic loci .,The analysis of [ tumors | Disease ] from 54 ( 71 % ) of 76 informative patients showed loss of constitutional heterozygosity ( LOH ) at intragenic loci. ,O O O B-Disease O O O O O O O O O O O O O O O O O O O O O O 
25,Three of 13 uninformative patients had constitutional deletions .,Three of 13 uninformative patients had constitutional deletions. ,O O O O O O O O O 
26,"For 39 randomly selected tumors , SSCP , hetero - duplex analysis , sequencing , and Southern blot analysis were used to identify mutations .","For 39 randomly selected [ tumors | Disease ], SSCP, hetero - duplex analysis, sequencing, and Southern blot analysis were used to identify mutations. ",O O O O B-Disease O O O O O O O O O O O O O O O O O O O O 
27,Mutations were detected in 21 ( 91 % ) of 23 tumors with LOH .,Mutations were detected in 21 ( 91 % ) of 23 [ tumors | Disease ] with LOH. ,O O O O O O O O O O O B-Disease O O O 
28,"In 6 ( 38 % ) of 16 tumors without LOH , one mutation was detected , and in 9 ( 56 % ) of the tumors without LOH , both mutations were found .","In 6 ( 38 % ) of 16 [ tumors | Disease ] without LOH, one mutation was detected, and in 9 ( 56 % ) of the [ tumors | Disease ] without LOH, both mutations were found. ",O O O O O O O O B-Disease O O O O O O O O O O O O O O O O O B-Disease O O O O O O O O 
29,"Thus , a total of 45 mutations were identified in tumors of 36 patients .","Thus, a total of 45 mutations were identified in [ tumors | Disease ] of 36 patients. ",O O O O O O O O O O B-Disease O O O O 
30,"Thirty - nine of the mutations - including 34 small mutations , 2 large structural alterations , and hypermethylation in 3 tumors - were not detected in the corresponding peripheral blood DNA .","Thirty - nine of the mutations - including 34 small mutations, 2 large structural alterations, and hypermethylation in 3 tumors - were not detected in the corresponding peripheral blood DNA. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
31,"In 6 ( 17 % ) of the 36 patients , a mutation was detected in constitutional DNA , and 1 of these mutations is known to be associated with reduced expressivity .","In 6 ( 17 % ) of the 36 patients, a mutation was detected in constitutional DNA, and 1 of these mutations is known to be associated with reduced expressivity. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
32,The presence of a constitutional mutation was not associated with an early age at treatment .,The presence of a constitutional mutation was not associated with an early age at treatment. ,O O O O O O O O O O O O O O O O 
33,"In 1 patient , somatic mosaicism was demonstrated by molecular analysis of DNA and RNA from peripheral blood .","In 1 patient, somatic mosaicism was demonstrated by molecular analysis of DNA and RNA from peripheral blood. ",O O O O O O O O O O O O O O O O O O O 
34,"In 2 patients without a detectable mutation in peripheral blood , mosaicism was suggested because 1 of the patients showed multifocal tumors and the other later developed bilateral retinoblastoma .","In 2 patients without a detectable mutation in peripheral blood, mosaicism was suggested because 1 of the patients showed multifocal [ tumors | Disease ] and the other later developed  [ bilateral retinoblastoma | Disease ]. ",O O O O O O O O O O O O O O O O O O O O O B-Disease O O O O O B-Disease I-Disease O 
35,"In conclusion , our results emphasize that the manifestation and transmissibility of retinoblastoma depend on the nature of the first mutation , its time in development , and the number and types of cells that are affected . .","In conclusion, our results emphasize that the manifestation and transmissibility of [ retinoblastoma | Disease ] depend on the nature of the first mutation, its time in development, and the number and types of cells that are affected.. ",O O O O O O O O O O O O B-Disease O O O O O O O O O O O O O O O O O O O O O O O O O O 
36,Hereditary deficiency of the fifth component of complement in man .,       [ Hereditary deficiency of the fifth component of complement | Disease ] in man. ,B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O O O 
37,I .,I. ,O O 
38,"Clinical , immunochemical , and family studies .","Clinical, immunochemical, and family studies. ",O O O O O O O O 
39,The first recognized human kindred with hereditary deficiency of the fifth component of complement ( C5 ) is described .,The first recognized human kindred with        [ hereditary deficiency of the fifth component of complement | Disease ] ( C5 ) is described. ,O O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O O O O O O 
40,"The proband , a 20 - year - old black female with systemic lupus erythematosus since age 11 , lacked serum hemolytic complement activity , even during remission .","The proband, a 20 - year - old black female with   [ systemic lupus erythematosus | Disease ] since age 11, lacked serum hemolytic complement activity, even during remission. ",O O O O O O O O O O O O B-Disease I-Disease I-Disease O O O O O O O O O O O O O O 
41,C5 was undetectable in her serum by both immunodiffusion and hemolytic assays .,C5 was undetectable in her serum by both immunodiffusion and hemolytic assays. ,O O O O O O O O O O O O O 
42,"Other complement components were normal during remission of lupus , but C1 , C4 , C2 , and C3 levels fell during exacerbations .","Other complement components were normal during remission of lupus, but C1, C4, C2, and C3 levels fell during exacerbations. ",O O O O O O O O O O O O O O O O O O O O O O O O 
43,"A younger half - sister , who had no underlying disease , was also found to lack immunochemically detectable C5 .","A younger half - sister, who had no underlying disease, was also found to lack immunochemically detectable C5. ",O O O O O O O O O O O O O O O O O O O O O 
44,"By hemolytic assay , she exhibited 1 - 2 % of the normal serum C5 level and normal concentrations of other complement components .","By hemolytic assay, she exhibited 1 - 2 % of the normal serum C5 level and normal concentrations of other complement components. ",O O O O O O O O O O O O O O O O O O O O O O O O 
45,"C5 levels of other family members were either normal or approximately half - normal , consistent with autosomal codominant inheritance of the gene determining C5 deficiency .","C5 levels of other family members were either normal or approximately half - normal, consistent with autosomal codominant inheritance of the gene determining  [ C5 deficiency | Disease ]. ",O O O O O O O O O O O O O O O O O O O O O O O O B-Disease I-Disease O 
46,Normal hemolytic titers were restored to both homozygous C5 - deficient ( C5D ) sera by addition of highly purified human C5 .,Normal hemolytic titers were restored to both homozygous   [ C5 - deficient | Disease ] ( [ C5D | Disease ] ) sera by addition of highly purified human C5. ,O O O O O O O O B-Disease I-Disease I-Disease O B-Disease O O O O O O O O O O 
47,"In specific C5 titrations , however , it was noted that when limited amounts of C5 were assayed in the presence of low dilutions of either C5D serum , curving rather than linear dose - response plots were consistently obtained , suggesting some inhibitory effect .","In specific C5 titrations, however, it was noted that when limited amounts of C5 were assayed in the presence of low dilutions of either [ C5D | Disease ] serum, curving rather than linear dose - response plots were consistently obtained, suggesting some inhibitory effect. ",O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease O O O O O O O O O O O O O O O O O O O 
48,"Further studies suggested that low dilutions of C5D serum contain a factor ( or factors ) interfering at some step in the hemolytic assay of C5 , rather than a true C5 inhibitor or inactivator .","Further studies suggested that low dilutions of [ C5D | Disease ] serum contain a factor ( or factors ) interfering at some step in the hemolytic assay of C5, rather than a true C5 inhibitor or inactivator. ",O O O O O O O B-Disease O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
49,"Of clinical interest are ( a ) the documentation of membranous glomerulonephritis , vasculitis , and arthritis in an individual lacking C5 ( and its biologic functions ) , and ( b ) a remarkable propensity to bacterial infections in the proband , even during periods of low - dose or alternate - day corticosteroid therapy .","Of clinical interest are ( a ) the documentation of membranous [ glomerulonephritis | Disease ], [ vasculitis | Disease ], and [ arthritis | Disease ] in an individual lacking C5 ( and its biologic functions ), and ( b ) a remarkable propensity to  [ bacterial infections | Disease ] in the proband, even during periods of low - dose or alternate - day corticosteroid therapy. ",O O O O O O O O O O O B-Disease O B-Disease O O B-Disease O O O O O O O O O O O O O O O O O O O O B-Disease I-Disease O O O O O O O O O O O O O O O O O O 
50,Other observations indicate that the C5D state is compatible with normal coagulation function and the capacity to mount a neutrophilic leukocytosis during pyogenic infection . .,Other observations indicate that the [ C5D | Disease ] state is compatible with normal coagulation function and the capacity to mount a neutrophilic leukocytosis during  [ pyogenic infection | Disease ].. ,O O O O O B-Disease O O O O O O O O O O O O O O O O B-Disease I-Disease O O 
51,"Susceptibility to ankylosing spondylitis in twins : the role of genes , HLA , and the environment .","Susceptibility to  [ ankylosing spondylitis | Disease ] in twins : the role of genes, HLA, and the environment. ",O O B-Disease I-Disease O O O O O O O O O O O O O O 
52,OBJECTIVE To determine the relative effects of genetic and environmental factors in susceptibility to ankylosing spondylitis ( AS ) .,OBJECTIVE To determine the relative effects of genetic and environmental factors in susceptibility to  [ ankylosing spondylitis | Disease ] ( [ AS | Disease ] ). ,O O O O O O O O O O O O O O B-Disease I-Disease O B-Disease O O 
53,METHODS Twins with AS were identified from the Royal National Hospital for Rheumatic Diseases database .,METHODS Twins with [ AS | Disease ] were identified from the Royal National Hospital for  [ Rheumatic Diseases | Disease ] database. ,O O O B-Disease O O O O O O O O B-Disease I-Disease O O 
54,"Clinical and radiographic examinations were performed to establish diagnoses , and disease severity was assessed using a combination of validated scoring systems .","Clinical and radiographic examinations were performed to establish diagnoses, and disease severity was assessed using a combination of validated scoring systems. ",O O O O O O O O O O O O O O O O O O O O O O O 
55,"HLA typing for HLA - B27 , HLA - B60 , and HLA - DR1 was performed by polymerase chain reaction with sequence - specific primers , and zygosity was assessed using microsatellite markers .","HLA typing for HLA - B27, HLA - B60, and HLA - DR1 was performed by polymerase chain reaction with sequence - specific primers, and zygosity was assessed using microsatellite markers. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
56,"Genetic and environmental variance components were assessed with the program Mx , using data from this and previous studies of twins with AS .","Genetic and environmental variance components were assessed with the program Mx, using data from this and previous studies of twins with [ AS | Disease ]. ",O O O O O O O O O O O O O O O O O O O O O O B-Disease O 
57,"RESULTS Six of 8 monozygotic ( MZ ) twin pairs were disease concordant , compared with 4 of 15 B27 - positive dizygotic ( DZ ) twin pairs ( 27 % ) and 4 of 32 DZ twin pairs overall ( 12 . 5 % ) .","RESULTS Six of 8 monozygotic ( MZ ) twin pairs were disease concordant, compared with 4 of 15 B27 - positive dizygotic ( DZ ) twin pairs ( 27 % ) and 4 of 32 DZ twin pairs overall ( 12. 5 % ). ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
58,Nonsignificant increases in similarity with regard to age at disease onset and all of the disease severity scores assessed were noted in disease - concordant MZ twins compared with concordant DZ twins .,Nonsignificant increases in similarity with regard to age at disease onset and all of the disease severity scores assessed were noted in disease - concordant MZ twins compared with concordant DZ twins. ,O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
59,"HLA - B27 and B60 were associated with the disease in probands , and the rate of disease concordance was significantly increased among DZ twin pairs in which the co - twin was positive for both B27 and DR1 .","HLA - B27 and B60 were associated with the disease in probands, and the rate of disease concordance was significantly increased among DZ twin pairs in which the co - twin was positive for both B27 and DR1. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
60,Additive genetic effects were estimated to contribute 97 % of the population variance .,Additive genetic effects were estimated to contribute 97 % of the population variance. ,O O O O O O O O O O O O O O 
61,"CONCLUSION Susceptibility to AS is largely genetically determined , and the environmental trigger for the disease is probably ubiquitous .","CONCLUSION Susceptibility to [ AS | Disease ] is largely genetically determined, and the environmental trigger for the disease is probably ubiquitous. ",O O O B-Disease O O O O O O O O O O O O O O O O 
62,HLA - B27 accounts for a minority of the overall genetic susceptibility to AS .,HLA - B27 accounts for a minority of the overall genetic susceptibility to [ AS | Disease ]. ,O O O O O O O O O O O O O B-Disease O 
63,Cell cycle - dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains .,Cell cycle - dependent colocalization of BARD1 and BRCA1 proteins in discrete nuclear domains. ,O O O O O O O O O O O O O O O 
64,Germ - line mutations of the BRCA1 gene predispose women to early - onset breast and ovarian cancer by compromising the genes presumptive function as a tumor suppressor .,Germ - line mutations of the BRCA1 gene predispose women to early - onset    [ breast and ovarian cancer | Disease ] by compromising the genes presumptive function as a [ tumor | Disease ] suppressor. ,O O O O O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease O O O O O O O O B-Disease O O 
65,"Although the biochemical properties of BRCA1 polypeptides are not understood , their expression pattern and subcellular localization suggest a role in cell - cycle regulation .","Although the biochemical properties of BRCA1 polypeptides are not understood, their expression pattern and subcellular localization suggest a role in cell - cycle regulation. ",O O O O O O O O O O O O O O O O O O O O O O O O O O 
66,"When resting cells are induced to proliferate , the steady - state levels of BRCA1 increase in late G1 and reach a maximum during S phase .","When resting cells are induced to proliferate, the steady - state levels of BRCA1 increase in late G1 and reach a maximum during S phase. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O 
67,"Moreover , in S phase cells , BRCA1 polypeptides are hyperphosphorylated and accumulate into discrete subnuclear foci termed "" BRCA1 nuclear dots .","Moreover, in S phase cells, BRCA1 polypeptides are hyperphosphorylated and accumulate into discrete subnuclear foci termed "" BRCA1 nuclear dots. ",O O O O O O O O O O O O O O O O O O O O O O O 
68,"Recent studies demonstrated the existence of a genetically distinct , usually lethal form of the Schwartz - Jampel syndrome ( SJS ) of myotonia and skeletal dysplasia , which we called SJS type 2 .","Recent studies demonstrated the existence of a genetically distinct, usually lethal form of the    [ Schwartz - Jampel syndrome | Disease ] ( [ SJS | Disease ] ) of [ myotonia | Disease ] and  [ skeletal dysplasia | Disease ], which we called   [ SJS type 2 | Disease ]. ",O O O O O O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease O B-Disease O O B-Disease O B-Disease I-Disease O O O O B-Disease I-Disease I-Disease O 
69,"This disorder is reminiscent of another rare condition , the Stuve - Wiedemann syndrome ( SWS ) , which comprises campomelia at birth with skeletal dysplasia , contractures , and early death .","This disorder is reminiscent of another rare condition, the    [ Stuve - Wiedemann syndrome | Disease ] ( [ SWS | Disease ] ), which comprises [ campomelia | Disease ] at birth with  [ skeletal dysplasia | Disease ], [ contractures | Disease ], and  [ early death | Disease ]. ",O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease O B-Disease O O O O B-Disease O O O B-Disease I-Disease O B-Disease O O B-Disease I-Disease O 
70,"To test for possible nosologic identity between these disorders , we reviewed the literature and obtained a follow - up of the only two surviving patients , one with SJS type 2 at age 10 years and another with SWS at age 7 years .","To test for possible nosologic identity between these disorders, we reviewed the literature and obtained a follow - up of the only two surviving patients, one with   [ SJS type 2 | Disease ] at age 10 years and another with [ SWS | Disease ] at age 7 years. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease I-Disease I-Disease O O O O O O O B-Disease O O O O O 
71,"Patients reported as having either neonatal SJS or SWS presented a combination of a severe , prenatal - onset neuromuscular disorder ( with congenital joint contractures , respiratory and feeding difficulties , tendency to hyperthermia , and frequent death in infancy ) with a distinct campomelic - metaphyseal skeletal dysplasia .","Patients reported as having either neonatal [ SJS | Disease ] or [ SWS | Disease ] presented a combination of a severe, prenatal - onset  [ neuromuscular disorder | Disease ] ( with   [ congenital joint contractures | Disease ], respiratory and feeding difficulties, tendency to [ hyperthermia | Disease ], and frequent death in infancy ) with a distinct     [ campomelic - metaphyseal skeletal dysplasia | Disease ]. ",O O O O O O B-Disease O B-Disease O O O O O O O O O O B-Disease I-Disease O O B-Disease I-Disease I-Disease O O O O O O O O B-Disease O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease O 
72,The similarity of the clinical and radiographic findings is so extensive that these disorders appear to be a single entity .,The similarity of the clinical and radiographic findings is so extensive that these disorders appear to be a single entity. ,O O O O O O O O O O O O O O O O O O O O O 
73,"The follow - up observation of an identical and unique pattern of progressive bone dysplasia in the two patients ( one with SJS type 2 , one with SWS ) surviving beyond infancy adds to the evidence in favor of identity .","The follow - up observation of an identical and unique pattern of progressive  [ bone dysplasia | Disease ] in the two patients ( one with   [ SJS type 2 | Disease ], one with [ SWS | Disease ] ) surviving beyond infancy adds to the evidence in favor of identity. ",O O O O O O O O O O O O O B-Disease I-Disease O O O O O O O B-Disease I-Disease I-Disease O O O B-Disease O O O O O O O O O O O O O 
74,The hypothesis that SWS and SJS type 2 are the same disorder should be testable by molecular methods . .,The hypothesis that [ SWS | Disease ] and   [ SJS type 2 | Disease ] are the same disorder should be testable by molecular methods.. ,O O O B-Disease O B-Disease I-Disease I-Disease O O O O O O O O O O O O 
75,A mouse model of severe von Willebrand disease : defects in hemostasis and thrombosis .,A mouse model of severe   [ von Willebrand disease | Disease ] : defects in hemostasis and [ thrombosis | Disease ]. ,O O O O O B-Disease I-Disease I-Disease O O O O O B-Disease O 
76,von Willebrand factor ( vWf ) deficiency causes severe von Willebrand disease in humans .,      [ von Willebrand factor ( vWf ) deficiency | Disease ] causes severe   [ von Willebrand disease | Disease ] in humans. ,B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O O B-Disease I-Disease I-Disease O O O 
77,We generated a mouse model for this disease by using gene targeting .,We generated a mouse model for this disease by using gene targeting. ,O O O O O O O O O O O O O 
78,vWf - deficient mice appeared normal at birth ; they were viable and fertile .,  [ vWf - deficient | Disease ] mice appeared normal at birth ; they were viable and fertile. ,B-Disease I-Disease I-Disease O O O O O O O O O O O O 
79,"Neither vWf nor vWf propolypeptide ( von Willebrand antigen II ) were detectable in plasma , platelets , or endothelial cells of the homozygous mutant mice .","Neither vWf nor vWf propolypeptide (  [ von Willebrand | Disease ] antigen II ) were detectable in plasma, platelets, or endothelial cells of the homozygous mutant mice. ",O O O O O O B-Disease I-Disease O O O O O O O O O O O O O O O O O O O 
80,The mutant mice exhibited defects in hemostasis with a highly prolonged bleeding time and spontaneous bleeding events in approximately 10 % of neonates .,The mutant mice exhibited defects in hemostasis with a highly prolonged bleeding time and spontaneous bleeding events in approximately 10 % of neonates. ,O O O O O O O O O O O O O O O O O O O O O O O O 
81,"As in the human disease , the factor VIII level in these mice was reduced strongly as a result of the lack of protection provided by vWf .","As in the human disease, the factor VIII level in these mice was reduced strongly as a result of the lack of protection provided by vWf. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
82,Defective thrombosis in mutant mice was also evident in an in vivo model of vascular injury .,Defective [ thrombosis | Disease ] in mutant mice was also evident in an in vivo model of  [ vascular injury | Disease ]. ,O B-Disease O O O O O O O O O O O O B-Disease I-Disease O 
83,"In this model , the exteriorized mesentery was superfused with ferric chloride and the accumulation of fluorescently labeled platelets was observed by intravital microscopy .","In this model, the exteriorized mesentery was superfused with ferric chloride and the accumulation of fluorescently labeled platelets was observed by intravital microscopy. ",O O O O O O O O O O O O O O O O O O O O O O O O O 
84,We conclude that these mice very closely mimic severe human von Willebrand disease and will be very useful for investigating the role of vWf in normal physiology and in disease models . .,We conclude that these mice very closely mimic severe human   [ von Willebrand disease | Disease ] and will be very useful for investigating the role of vWf in normal physiology and in disease models.. ,O O O O O O O O O O B-Disease I-Disease I-Disease O O O O O O O O O O O O O O O O O O O O 
85,Oral contraceptives and the risk of hereditary ovarian cancer .,Oral contraceptives and the risk of   [ hereditary ovarian cancer | Disease ]. ,O O O O O O B-Disease I-Disease I-Disease O 
86,Hereditary Ovarian Cancer Clinical Study Group .,  [ Hereditary Ovarian Cancer | Disease ] Clinical Study Group. ,B-Disease I-Disease I-Disease O O O O 
87,BACKGROUND Women with mutations in either the BRCA1 or the BRCA2 gene have a high lifetime risk of ovarian cancer .,BACKGROUND Women with mutations in either the BRCA1 or the BRCA2 gene have a high lifetime risk of  [ ovarian cancer | Disease ]. ,O O O O O O O O O O O O O O O O O O B-Disease I-Disease O 
88,"Oral contraceptives protect against ovarian cancer in general , but it is not known whether they also protect against hereditary forms of ovarian cancer .","Oral contraceptives protect against  [ ovarian cancer | Disease ] in general, but it is not known whether they also protect against     [ hereditary forms of ovarian cancer | Disease ]. ",O O O O B-Disease I-Disease O O O O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease O 
89,METHODS We enrolled 207 women with hereditary ovarian cancer and 161 of their sisters as controls in a case - control study .,METHODS We enrolled 207 women with   [ hereditary ovarian cancer | Disease ] and 161 of their sisters as controls in a case - control study. ,O O O O O O B-Disease I-Disease I-Disease O O O O O O O O O O O O O O 
90,All the patients carried a pathogenic mutation in either BRCA1 ( 179 women ) or BRCA2 ( 28 women ) .,All the patients carried a pathogenic mutation in either BRCA1 ( 179 women ) or BRCA2 ( 28 women ). ,O O O O O O O O O O O O O O O O O O O O O 
91,The control women were enrolled regardless of whether or not they had either mutation .,The control women were enrolled regardless of whether or not they had either mutation. ,O O O O O O O O O O O O O O O 
92,"Lifetime histories of oral - contraceptive use were obtained by interview or by written questionnaire and were compared between patients and control women , after adjustment for year of birth and parity .","Lifetime histories of oral - contraceptive use were obtained by interview or by written questionnaire and were compared between patients and control women, after adjustment for year of birth and parity. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
93,RESULTS The adjusted odds ratio for ovarian cancer associated with any past use of oral contraceptives was 0 .,RESULTS The adjusted odds ratio for  [ ovarian cancer | Disease ] associated with any past use of oral contraceptives was 0. ,O O O O O O B-Disease I-Disease O O O O O O O O O O O 
94,"5 ( 95 percent confidence interval , 0 . 3 to 0 . 8 ) .","5 ( 95 percent confidence interval, 0. 3 to 0. 8 ). ",O O O O O O O O O O O O O O O O 
95,"The risk decreased with increasing duration of use ( P for trend , < 0 . 001 ) ; use for six or more years was associated with a 60 percent reduction in risk .","The risk decreased with increasing duration of use ( P for trend, < 0. 001 ) ; use for six or more years was associated with a 60 percent reduction in risk. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
96,"Oral - contraceptive use protected against ovarian cancer both for carriers of the BRCA1 mutation ( odds ratio , 0 . 5 ; 95 percent confidence interval , 0 . 3 to 0 . 9 ) and for carriers of the BRCA2 mutation ( odds ratio , 0 . 4 ; 95 percent confidence interval , 0 . 2 to 1 . 1 ) .","Oral - contraceptive use protected against  [ ovarian cancer | Disease ] both for carriers of the BRCA1 mutation ( odds ratio, 0. 5 ; 95 percent confidence interval, 0. 3 to 0. 9 ) and for carriers of the BRCA2 mutation ( odds ratio, 0. 4 ; 95 percent confidence interval, 0. 2 to 1. 1 ). ",O O O O O O B-Disease I-Disease O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
97,CONCLUSIONS Oral - contraceptive use may reduce the risk of ovarian cancer in women with pathogenic mutations in the BRCA1 or BRCA2 gene,CONCLUSIONS Oral - contraceptive use may reduce the risk of  [ ovarian cancer | Disease ] in women with pathogenic mutations in the BRCA1 or BRCA2 gene ,O O O O O O O O O O B-Disease I-Disease O O O O O O O O O O O 
98,"A Japanese family with adrenoleukodystrophy with a codon 291 deletion : a clinical , biochemical , pathological , and genetic report .","A Japanese family with [ adrenoleukodystrophy | Disease ] with a codon 291 deletion : a clinical, biochemical, pathological, and genetic report. ",O O O O B-Disease O O O O O O O O O O O O O O O O O 
99,We report a Japanese family with adrenoleukodystrophy ( ALD ) with a three base pair deletion ( delGAG 291 ) in the ALD gene .,We report a Japanese family with [ adrenoleukodystrophy | Disease ] ( [ ALD | Disease ] ) with a three base pair deletion ( delGAG 291 ) in the [ ALD | Disease ] gene. ,O O O O O O B-Disease O B-Disease O O O O O O O O O O O O O B-Disease O O 
100,A variety of phenotypes were observed within this family .,A variety of phenotypes were observed within this family. ,O O O O O O O O O O 
101,"While the proband ( patient 1 ) was classified as having a rare intermediate type of adult cerebral and cerebello - brain stem forms , his younger brother ( patient 2 ) and nephew ( patient 3 ) had a childhood ALD type .","While the proband ( patient 1 ) was classified as having a rare intermediate type of adult cerebral and cerebello - brain stem forms, his younger brother ( patient 2 ) and nephew ( patient 3 ) had a childhood [ ALD | Disease ] type. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease O O 
102,Another nephew ( patient 4 ) of patient 1 was classified as having an adolescent form .,Another nephew ( patient 4 ) of patient 1 was classified as having an adolescent form. ,O O O O O O O O O O O O O O O O O 
103,The tau level in the cerebrospinal fluid ( CSF ) in patient 1 was as high as that of patients with Alzheimers disease ( AD ) .,The tau level in the cerebrospinal fluid ( CSF ) in patient 1 was as high as that of patients with  [ Alzheimers disease | Disease ] ( [ AD | Disease ] ). ,O O O O O O O O O O O O O O O O O O O O O B-Disease I-Disease O B-Disease O O 
104,"His brain magnetic resonance image ( MRI ) showed abnormalities in the bilateral cerebellar hemispheres and brain stem , but not in the cerebral white matter , where marked reductions of the cerebral blood flow and oxygen metabolism were clearly demonstrated by positron emission tomography ( PET ) .","His brain magnetic resonance image ( MRI ) showed      [ abnormalities in the bilateral cerebellar hemispheres | Disease ] and brain stem, but not in the cerebral white matter, where marked reductions of the cerebral blood flow and oxygen metabolism were clearly demonstrated by positron emission tomography ( PET ). ",O O O O O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
105,"In patients 2 and 3 , the autopsy findings showed massive demyelination of the cerebral white matter with sparing of the U - fibers , compatible with the findings of childhood ALD .","In patients 2 and 3, the autopsy findings showed massive      [ demyelination of the cerebral white matter | Disease ] with sparing of the U - fibers, compatible with the findings of childhood [ ALD | Disease ]. ",O O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O O O O O O O O O O O O O O B-Disease O 
106,"Oleic and erucic acids ( Lorenzos Oil ) were administered to patients 1 and 4 , but sufficient effectiveness was not obtained .","Oleic and erucic acids ( Lorenzos Oil ) were administered to patients 1 and 4, but sufficient effectiveness was not obtained. ",O O O O O O O O O O O O O O O O O O O O O O O 
107,The findings in this family suggest that delGAG291 is part of the cause of Japanese ALD with phenotypic variations .,The findings in this family suggest that delGAG291 is part of the cause of Japanese [ ALD | Disease ] with phenotypic variations. ,O O O O O O O O O O O O O O O B-Disease O O O O 
108,"Moreover , although the scale of the study is limited , there is a possibility that PET can detect an insidious lesion which is undetectable by computed tomogram ( CT ) or MRI analysis , and that the higher level of tau reflects the process of neuronal degeneration in ALD .","Moreover, although the scale of the study is limited, there is a possibility that PET can detect an  [ insidious lesion | Disease ] which is undetectable by computed tomogram ( CT ) or MRI analysis, and that the higher level of tau reflects the process of  [ neuronal degeneration | Disease ] in [ ALD | Disease ]. ",O O O O O O O O O O O O O O O O O O O O B-Disease I-Disease O O O O O O O O O O O O O O O O O O O O O O O O B-Disease I-Disease O B-Disease O 
109,Lorenzos Oil should be given in the early stage . .,Lorenzos Oil should be given in the early stage.. ,O O O O O O O O O O O 
110,Nonsense mutation in exon 4 of human complement C9 gene is the major cause of Japanese complement C9 deficiency .,Nonsense mutation in exon 4 of human complement C9 gene is the major cause of Japanese   [ complement C9 deficiency | Disease ]. ,O O O O O O O O O O O O O O O O B-Disease I-Disease I-Disease O 
111,Deficiency of the ninth component of human complement ( C9 ) is the most common complement deficiency in Japan but is rare in other countries .,       [ Deficiency of the ninth component of human complement | Disease ] ( C9 ) is the most common  [ complement deficiency | Disease ] in Japan but is rare in other countries. ,B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O O O O O O O B-Disease I-Disease O O O O O O O O O 
112,We studied the molecular basis of C9 deficiency in four Japanese C9 - deficient patients who had suffered from meningococcal meningitis .,We studied the molecular basis of  [ C9 deficiency | Disease ] in four Japanese   [ C9 - deficient | Disease ] patients who had suffered from  [ meningococcal meningitis | Disease ]. ,O O O O O O B-Disease I-Disease O O O B-Disease I-Disease I-Disease O O O O O B-Disease I-Disease O 
113,Direct sequencing of amplified C9 cDNA and DNA revealed a nonsense substitution ( CGA - - > TGA ) at codon 95 in exon 4 in the four C9 - deficient individuals .,Direct sequencing of amplified C9 cDNA and DNA revealed a nonsense substitution ( CGA - - > TGA ) at codon 95 in exon 4 in the four   [ C9 - deficient | Disease ] individuals. ,O O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease I-Disease I-Disease O O 
114,An allele - specific polymerase chain reaction system designed to detect exclusively only one of the normal and mutant alleles indicated that all the four patients were homozygous for the mutation in exon 4 and that the parents of patient 2 were heterozygous .,An allele - specific polymerase chain reaction system designed to detect exclusively only one of the normal and mutant alleles indicated that all the four patients were homozygous for the mutation in exon 4 and that the parents of patient 2 were heterozygous. ,O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
115,The common mutation at codon 95 in exon 4 might be responsible for most Japanese C9 deficiency . .,The common mutation at codon 95 in exon 4 might be responsible for most Japanese  [ C9 deficiency | Disease ].. ,O O O O O O O O O O O O O O O B-Disease I-Disease O O 
116,BRCA1 required for transcription - coupled repair of oxidative DNA damage .,BRCA1 required for transcription - coupled repair of oxidative DNA damage. ,O O O O O O O O O O O O 
117,The breast and ovarian cancer susceptibility gene BRCA1 encodes a zinc finger protein of unknown function .,The    [ breast and ovarian cancer | Disease ] susceptibility gene BRCA1 encodes a zinc finger protein of unknown function. ,O B-Disease I-Disease I-Disease I-Disease O O O O O O O O O O O O 
118,Association of the BRCA1 protein with the DNA repair protein Rad51 and changes in the phosphorylation and cellular localization of the protein after exposure to DNA - damaging agents are consistent with a role for BRCA1 in DNA repair .,Association of the BRCA1 protein with the DNA repair protein Rad51 and changes in the phosphorylation and cellular localization of the protein after exposure to DNA - damaging agents are consistent with a role for BRCA1 in DNA repair. ,O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
119,"Here , it is shown that mouse embryonic stem cells deficient in BRCA1 are defective in the ability to carry out transcription - coupled repair of oxidative DNA damage , and are hypersensitive to ionizing radiation and hydrogen peroxide .","Here, it is shown that mouse embryonic stem cells   [ deficient in BRCA1 | Disease ] are defective in the ability to carry out transcription - coupled repair of oxidative DNA damage, and are hypersensitive to ionizing radiation and hydrogen peroxide. ",O O O O O O O O O O B-Disease I-Disease I-Disease O O O O O O O O O O O O O O O O O O O O O O O O O O O 
120,"These results suggest that BRCA1 participates , directly or indirectly , in transcription - coupled repair of oxidative DNA damage . .","These results suggest that BRCA1 participates, directly or indirectly, in transcription - coupled repair of oxidative DNA damage.. ",O O O O O O O O O O O O O O O O O O O O O O 
121,Truncation mutations in the transactivation region of PAX6 result in dominant - negative mutants .,Truncation mutations in the transactivation region of PAX6 result in dominant - negative mutants. ,O O O O O O O O O O O O O O O 
122,PAX6 is a transcription factor with two DNA - binding domains ( paired box and homeobox ) and a proline - serine - threonine ( PST ) - rich transactivation domain .,PAX6 is a transcription factor with two DNA - binding domains ( paired box and homeobox ) and a proline - serine - threonine ( PST ) - rich transactivation domain. ,O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
123,PAX6 regulates eye development in animals ranging from jellyfish to Drosophila to humans .,PAX6 regulates eye development in animals ranging from jellyfish to Drosophila to humans. ,O O O O O O O O O O O O O O 
124,"Heterozygous mutations in the human PAX6 gene result in various phenotypes , including aniridia , Peters anomaly , autosomal dominant keratitis , and familial foveal dysplasia .","Heterozygous mutations in the human PAX6 gene result in various phenotypes, including [ aniridia | Disease ],  [ Peters anomaly | Disease ],   [ autosomal dominant keratitis | Disease ], and   [ familial foveal dysplasia | Disease ]. ",O O O O O O O O O O O O O B-Disease O B-Disease I-Disease O B-Disease I-Disease I-Disease O O B-Disease I-Disease I-Disease O 
125,It is believed that the mutated allele of PAX6 produces an inactive protein and aniridia is caused due to genetic haploinsufficiency .,It is believed that the mutated allele of PAX6 produces an inactive protein and [ aniridia | Disease ] is caused due to genetic haploinsufficiency. ,O O O O O O O O O O O O O O B-Disease O O O O O O O 
126,"However , several truncation mutations have been found to occur in the C - terminal half of PAX6 in patients with Aniridia resulting in mutant proteins that retain the DNA - binding domains but have lost most of the transactivation domain .","However, several truncation mutations have been found to occur in the C - terminal half of PAX6 in patients with [ Aniridia | Disease ] resulting in mutant proteins that retain the DNA - binding domains but have lost most of the transactivation domain. ",O O O O O O O O O O O O O O O O O O O O O B-Disease O O O O O O O O O O O O O O O O O O O O 
127,It is not clear whether such mutants really behave as loss - of - function mutants as predicted by haploinsufficiency .,It is not clear whether such mutants really behave as loss - of - function mutants as predicted by haploinsufficiency. ,O O O O O O O O O O O O O O O O O O O O O 
128,"Contrary to this theory , our data showed that these mutants are dominant - negative in transient transfection assays when they are coexpressed with wild - type PAX6 .","Contrary to this theory, our data showed that these mutants are dominant - negative in transient transfection assays when they are coexpressed with wild - type PAX6. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
129,We found that the dominant - negative effects result from the enhanced DNA binding ability of these mutants .,We found that the dominant - negative effects result from the enhanced DNA binding ability of these mutants. ,O O O O O O O O O O O O O O O O O O O 
130,Kinetic studies of binding and dissociation revealed that various truncation mutants have 3 - 5 - fold higher affinity to various DNA - binding sites when compared with the wild - type PAX6 .,Kinetic studies of binding and dissociation revealed that various truncation mutants have 3 - 5 - fold higher affinity to various DNA - binding sites when compared with the wild - type PAX6. ,O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
131,These results provide a new insight into the role of mutant PAX6 in causing aniridia . .,These results provide a new insight into the role of mutant PAX6 in causing [ aniridia | Disease ].. ,O O O O O O O O O O O O O O B-Disease O O 
132,Reversal of severe hypertrophic cardiomyopathy and excellent neuropsychologic outcome in very - long - chain acyl - coenzyme A dehydrogenase deficiency .,Reversal of severe  [ hypertrophic cardiomyopathy | Disease ] and excellent neuropsychologic outcome in           [ very - long - chain acyl - coenzyme A dehydrogenase deficiency | Disease ]. ,O O O B-Disease I-Disease O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O 
133,Very - long - chain acyl - coenzyme A dehydrogenase ( VLCAD ) deficiency is a disorder of fatty acid beta oxidation that reportedly has high rates of morbidity and mortality .,             [ Very - long - chain acyl - coenzyme A dehydrogenase ( VLCAD ) deficiency | Disease ] is a disorder of fatty acid beta oxidation that reportedly has high rates of morbidity and mortality. ,B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O O O O O O O O O O O O O O O O O O 
134,"We describe the outcome of a 5 - year - old girl with VLCAD deficiency who was first seen at 5 months of age with severe hypertrophic cardiomyopathy , hepatomegaly , encephalopathy , and hypotonia .","We describe the outcome of a 5 - year - old girl with  [ VLCAD deficiency | Disease ] who was first seen at 5 months of age with severe  [ hypertrophic cardiomyopathy | Disease ], [ hepatomegaly | Disease ], [ encephalopathy | Disease ], and [ hypotonia | Disease ]. ",O O O O O O O O O O O O O B-Disease I-Disease O O O O O O O O O O O B-Disease I-Disease O B-Disease O B-Disease O O B-Disease O 
135,Biochemical studies indicated VLCAD deficiency caused by a stable yet inactive enzyme .,Biochemical studies indicated  [ VLCAD deficiency | Disease ] caused by a stable yet inactive enzyme. ,O O O B-Disease I-Disease O O O O O O O O 
136,Molecular genetic analysis of her VLCAD gene revealed a T1372C ( F458L ) missense mutation and a 1668 ACAG 1669 splice site mutation .,Molecular genetic analysis of her VLCAD gene revealed a T1372C ( F458L ) missense mutation and a 1668 ACAG 1669 splice site mutation. ,O O O O O O O O O O O O O O O O O O O O O O O O 
137,"After initial treatment with intravenous glucose and carnitine , the patient has thrived on a low - fat diet supplemented with medium - chain triglyceride oil and carnitine and avoidance of fasting .","After initial treatment with intravenous glucose and carnitine, the patient has thrived on a low - fat diet supplemented with medium - chain triglyceride oil and carnitine and avoidance of fasting. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
138,"Her ventricular hypertrophy resolved significantly over 1 year , and cognitively , she is in the superior range for age .","Her ventricular hypertrophy resolved significantly over 1 year, and cognitively, she is in the superior range for age. ",O O O O O O O O O O O O O O O O O O O O O 
139,Clinical recognition of VLCAD deficiency is important because it is one of the few directly treatable causes of cardiomyopathy in children . .,Clinical recognition of  [ VLCAD deficiency | Disease ] is important because it is one of the few directly treatable causes of [ cardiomyopathy | Disease ] in children.. ,O O O B-Disease I-Disease O O O O O O O O O O O O O B-Disease O O O O 
140,Cloning of a novel member of the low - density lipoprotein receptor family .,Cloning of a novel member of the low - density lipoprotein receptor family. ,O O O O O O O O O O O O O O 
141,A gene encoding a novel transmembrane protein was identified by DNA sequence analysis within the insulin - dependent diabetes mellitus ( IDDM ) locus IDDM4 on chromosome 11q13 .,A gene encoding a novel transmembrane protein was identified by DNA sequence analysis within the     [ insulin - dependent diabetes mellitus | Disease ] ( [ IDDM | Disease ] ) locus IDDM4 on chromosome 11q13. ,O O O O O O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease O B-Disease O O O O O O O 
142,"Based on its chromosomal position , this gene is a candidate for conferring susceptibility to diabetes .","Based on its chromosomal position, this gene is a candidate for conferring susceptibility to [ diabetes | Disease ]. ",O O O O O O O O O O O O O O O B-Disease O 
143,"The gene , termed low - density lipoprotein receptor related protein 5 ( LRP5 ) , encodes a protein of 1615 amino acids that contains conserved modules which are characteristic of the low - density lipoprotein ( LDL ) receptor family .","The gene, termed low - density lipoprotein receptor related protein 5 ( LRP5 ), encodes a protein of 1615 amino acids that contains conserved modules which are characteristic of the low - density lipoprotein ( LDL ) receptor family. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
144,"These modules include a putative signal peptide for protein export , four epidermal growth factor ( EGF ) repeats with associated spacer domains , three LDL - receptor ( LDLR ) repeats , a single transmembrane spanning domain , and a cytoplasmic domain .","These modules include a putative signal peptide for protein export, four epidermal growth factor ( EGF ) repeats with associated spacer domains, three LDL - receptor ( LDLR ) repeats, a single transmembrane spanning domain, and a cytoplasmic domain. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
145,"The encoded protein has a unique organization of EGF and LDLR repeats ; therefore , LRP5 likely represents a new category of the LDLR family .","The encoded protein has a unique organization of EGF and LDLR repeats ; therefore, LRP5 likely represents a new category of the LDLR family. ",O O O O O O O O O O O O O O O O O O O O O O O O O O 
146,"Both human and mouse LRP5 cDNAs have been isolated and the encoded mature proteins are 95 % identical , indicating a high degree of evolutionary conservation . .","Both human and mouse LRP5 cDNAs have been isolated and the encoded mature proteins are 95 % identical, indicating a high degree of evolutionary conservation.. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
147,"The APC variants I1307K and E1317Q are associated with colorectal tumors , but not always with a family history .","The [ APC | Disease ] variants I1307K and E1317Q are associated with  [ colorectal tumors | Disease ], but not always with a family history. ",O B-Disease O O O O O O O B-Disease I-Disease O O O O O O O O O 
148,Classical familial adenomatous polyposis ( FAP ) is a high - penetrance autosomal dominant disease that predisposes to hundreds or thousands of colorectal adenomas and carcinoma and that results from truncating mutations in the APC gene .,Classical   [ familial adenomatous polyposis | Disease ] ( [ FAP | Disease ] ) is a high - penetrance   [ autosomal dominant disease | Disease ] that predisposes to hundreds or thousands of    [ colorectal adenomas and carcinoma | Disease ] and that results from truncating mutations in the [ APC | Disease ] gene. ,O B-Disease I-Disease I-Disease O B-Disease O O O O O O B-Disease I-Disease I-Disease O O O O O O O B-Disease I-Disease I-Disease I-Disease O O O O O O O O B-Disease O O 
149,"A variant of FAP is attenuated adenomatous polyposis coli , which results from germ - line mutations in the 5 and 3 regions of the APC gene .","A variant of [ FAP | Disease ] is    [ attenuated adenomatous polyposis coli | Disease ], which results from germ - line mutations in the 5 and 3 regions of the [ APC | Disease ] gene. ",O O O B-Disease O B-Disease I-Disease I-Disease I-Disease O O O O O O O O O O O O O O O O B-Disease O O 
150,"Attenuated adenomatous polyposis coli patients have "" multiple "" colorectal adenomas ( typically fewer than 100 ) without the florid phenotype of classical FAP .","   [ Attenuated adenomatous polyposis coli | Disease ] patients have "" multiple ""  [ colorectal adenomas | Disease ] ( typically fewer than 100 ) without the florid phenotype of classical [ FAP | Disease ]. ",B-Disease I-Disease I-Disease I-Disease O O O O O B-Disease I-Disease O O O O O O O O O O O O B-Disease O 
151,"Another group of patients with multiple adenomas has no mutations in the APC gene , and their phenotype probably results from variation at a locus , or loci , elsewhere in the genome .","Another group of patients with multiple [ adenomas | Disease ] has no mutations in the [ APC | Disease ] gene, and their phenotype probably results from variation at a locus, or loci, elsewhere in the genome. ",O O O O O O B-Disease O O O O O B-Disease O O O O O O O O O O O O O O O O O O O O O 
152,"Recently , however , a missense variant of APC ( I1307K ) was described that confers an increased risk of colorectal tumors , including multiple adenomas , in Ashkenazim .","Recently, however, a missense variant of [ APC | Disease ] ( I1307K ) was described that confers an increased risk of  [ colorectal tumors | Disease ], including multiple [ adenomas | Disease ], in Ashkenazim. ",O O O O O O O O B-Disease O O O O O O O O O O O B-Disease I-Disease O O O B-Disease O O O O 
153,We have studied a set of 164 patients with multiple colorectal adenomas and / or carcinoma and analyzed codons 1263 - 1377 ( exon 15G ) of the APC gene for germ - line variants .,We have studied a set of 164 patients with multiple      [ colorectal adenomas and / or carcinoma | Disease ] and analyzed codons 1263 - 1377 ( exon 15G ) of the [ APC | Disease ] gene for germ - line variants. ,O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O O O O O O O O O O O O B-Disease O O O O O O O 
154,"Three patients with the I1307K allele were detected , each of Ashkenazi descent .","Three patients with the I1307K allele were detected, each of Ashkenazi descent. ",O O O O O O O O O O O O O O 
155,Four patients had a germ - line E1317Q missense variant of APC that was not present in controls ; one of these individuals had an unusually large number of metaplastic polyps of the colorectum .,Four patients had a germ - line E1317Q missense variant of APC that was not present in controls ; one of these individuals had an unusually large number of     [ metaplastic polyps of the colorectum | Disease ]. ,O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease O 
156,"There is increasing evidence that there exist germ - line variants of the APC gene that predispose to the development of multiple colorectal adenomas and carcinoma , but without the florid phenotype of classical FAP , and possibly with importance for colorectal cancer risk in the general population . .","There is increasing evidence that there exist germ - line variants of the [ APC | Disease ] gene that predispose to the development of multiple    [ colorectal adenomas and carcinoma | Disease ], but without the florid phenotype of classical [ FAP | Disease ], and possibly with importance for  [ colorectal cancer | Disease ] risk in the general population.. ",O O O O O O O O O O O O O B-Disease O O O O O O O O B-Disease I-Disease I-Disease I-Disease O O O O O O O O B-Disease O O O O O O B-Disease I-Disease O O O O O O O 
157,Genomic structure of the human congenital chloride diarrhea ( CLD ) gene .,Genomic structure of the human   [ congenital chloride diarrhea | Disease ] ( [ CLD | Disease ] ) gene. ,O O O O O B-Disease I-Disease I-Disease O B-Disease O O O 
158,Congenital chloride diarrhea ( CLD ) is caused by mutations in a gene which encodes an intestinal anion transporter .,  [ Congenital chloride diarrhea | Disease ] ( [ CLD | Disease ] ) is caused by mutations in a gene which encodes an intestinal anion transporter. ,B-Disease I-Disease I-Disease O B-Disease O O O O O O O O O O O O O O O 
159,"We report here the complete genomic organization of the human CLD gene which spans approximately 39kb , and comprises 21 exons .","We report here the complete genomic organization of the human [ CLD | Disease ] gene which spans approximately 39kb, and comprises 21 exons. ",O O O O O O O O O O B-Disease O O O O O O O O O O O 
160,All exon / intron boundaries conform to the GT / AG rule .,All exon / intron boundaries conform to the GT / AG rule. ,O O O O O O O O O O O O O 
161,An analysis of the putative promoter region sequence shows a putative TATA box and predicts multiple transcription factor binding sites .,An analysis of the putative promoter region sequence shows a putative TATA box and predicts multiple transcription factor binding sites. ,O O O O O O O O O O O O O O O O O O O O O 
162,The genomic structure was determined using DNA from several sources including multiple large - insert libaries and genomic DNA from Finnish CLD patients and controls .,The genomic structure was determined using DNA from several sources including multiple large - insert libaries and genomic DNA from Finnish [ CLD | Disease ] patients and controls. ,O O O O O O O O O O O O O O O O O O O O O B-Disease O O O O 
163,Exon - specific primers developed in this study will facilitate mutation screening studies of patients with the disease .,Exon - specific primers developed in this study will facilitate mutation screening studies of patients with the disease. ,O O O O O O O O O O O O O O O O O O O 
164,"Genomic sequencing of a BAC clone H _ RG364P16 revealed the presence of another , highly homologous gene 3 of the CLD gene , with a similar genomic structure , recently identified as the Pendred syndrome gene ( PDS ) . .","Genomic sequencing of a BAC clone H _ RG364P16 revealed the presence of another, highly homologous gene 3 of the [ CLD | Disease ] gene, with a similar genomic structure, recently identified as the  [ Pendred syndrome | Disease ] gene ( [ PDS | Disease ] ).. ",O O O O O O O O O O O O O O O O O O O O O B-Disease O O O O O O O O O O O O B-Disease I-Disease O O B-Disease O O O 
165,The APCI1307K allele and cancer risk in a community - based study of Ashkenazi Jews .,The APCI1307K allele and [ cancer | Disease ] risk in a community - based study of Ashkenazi Jews. ,O O O O B-Disease O O O O O O O O O O O 
166,"Mutations in APC are classically associated with familial adenomatous polyposis ( FAP ) , a highly penetrant autosomal dominant disorder characterized by multiple intestinal polyps and , without surgical intervention , the development of colorectal cancer ( CRC ) .","Mutations in APC are classically associated with   [ familial adenomatous polyposis | Disease ] ( [ FAP | Disease ] ), a highly penetrant   [ autosomal dominant disorder | Disease ] characterized by multiple intestinal [ polyps | Disease ] and, without surgical intervention, the development of  [ colorectal cancer | Disease ] ( [ CRC | Disease ] ). ",O O O O O O O B-Disease I-Disease I-Disease O B-Disease O O O O O B-Disease I-Disease I-Disease O O O O B-Disease O O O O O O O O O B-Disease I-Disease O B-Disease O O 
167,"APC is a tumour - suppressor gene , and somatic loss occurs in tumours .","[ APC | Disease ] is a tumour - suppressor gene, and somatic loss occurs in [ tumours | Disease ]. ",B-Disease O O O O O O O O O O O O B-Disease O 
168,The germline T - to - A transversion responsible for the APC I1307K allele converts the wild - type sequence to a homopolymer tract ( A8 ) that is genetically unstable and prone to somatic mutation .,The germline T - to - A transversion responsible for the APC I1307K allele converts the wild - type sequence to a homopolymer tract ( A8 ) that is genetically unstable and prone to somatic mutation. ,O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
169,The I1307K allele was found in 6 .,The I1307K allele was found in 6. ,O O O O O O O O 
170,1 % of unselected Ashkenazi Jews and higher proportions of Ashkenazim with family or personal histories of CRC ( ref . 2 ) .,1 % of unselected Ashkenazi Jews and higher proportions of Ashkenazim with family or personal histories of [ CRC | Disease ] ( ref. 2 ). ,O O O O O O O O O O O O O O O O O B-Disease O O O O O O 
171,"To evaluate the role of I1307K in cancer , we genotyped 5 , 081 Ashkenazi volunteers in a community survey .","To evaluate the role of I1307K in [ cancer | Disease ], we genotyped 5, 081 Ashkenazi volunteers in a community survey. ",O O O O O O O B-Disease O O O O O O O O O O O O O 
172,"Risk of developing colorectal , breast and other cancers were compared between genotyped I1307K carriers and non - carriers and their first - degree relatives .","Risk of developing      [ colorectal , breast and other cancers | Disease ] were compared between genotyped I1307K carriers and non - carriers and their first - degree relatives. ",O O O B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O O O O O O O O O O O O O O O O O 
173,Sperm DNA analysis in a Friedreich ataxia premutation carrier suggests both meiotic and mitotic expansion in the FRDA gene .,Sperm DNA analysis in a  [ Friedreich ataxia | Disease ] premutation carrier suggests both meiotic and mitotic expansion in the [ FRDA | Disease ] gene. ,O O O O O B-Disease I-Disease O O O O O O O O O O B-Disease O O 
174,Friedreich ataxia is usually caused by an expansion of a GAA trinucleotide repeat in intron 1 of the FRDA gene ., [ Friedreich ataxia | Disease ] is usually caused by an expansion of a GAA trinucleotide repeat in intron 1 of the [ FRDA | Disease ] gene. ,B-Disease I-Disease O O O O O O O O O O O O O O O O B-Disease O O 
175,"Occasionally , a fully expanded allele has been found to arise from a premutation of 100 or less triplet repeats .","Occasionally, a fully expanded allele has been found to arise from a premutation of 100 or less triplet repeats. ",O O O O O O O O O O O O O O O O O O O O O 
176,We have examined the sperm DNA of a premutation carrier .,We have examined the sperm DNA of a premutation carrier. ,O O O O O O O O O O O 
177,This mans leucocyte DNA showed one normal allele and one allele of approximately 100 repeats .,This mans leucocyte DNA showed one normal allele and one allele of approximately 100 repeats. ,O O O O O O O O O O O O O O O O 
178,His sperm showed an expanded allele in a tight range centering on a size of approximately 320 trinucleotide repeats .,His sperm showed an expanded allele in a tight range centering on a size of approximately 320 trinucleotide repeats. ,O O O O O O O O O O O O O O O O O O O O 
179,His affected son has repeat sizes of 1040 and 540 .,His affected son has repeat sizes of 1040 and 540. ,O O O O O O O O O O O 
180,"These data suggest that expansion occurs in two stages , the first during meiosis followed by a second mitotic expansion .","These data suggest that expansion occurs in two stages, the first during meiosis followed by a second mitotic expansion. ",O O O O O O O O O O O O O O O O O O O O O 
181,"We also show that in all informative carrier father to affected child transmissions , with the notable exception of the premutation carrier , the expansion size decreases . .","We also show that in all informative carrier father to affected child transmissions, with the notable exception of the premutation carrier, the expansion size decreases.. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
182,The R496H mutation of arylsulfatase A does not cause metachromatic leukodystrophy .,The R496H mutation of arylsulfatase A does not cause  [ metachromatic leukodystrophy | Disease ]. ,O O O O O O O O O B-Disease I-Disease O 
183,Deficiency of arylsulfatase A ( ARSA ) enzyme activity causes metachromatic leukodystrophy ( MLD ) .,   [ Deficiency of arylsulfatase A | Disease ] ( ARSA ) enzyme activity causes  [ metachromatic leukodystrophy | Disease ] ( [ MLD | Disease ] ). ,B-Disease I-Disease I-Disease I-Disease O O O O O O B-Disease I-Disease O B-Disease O O 
184,A number of ARSA gene mutations responsible for MLD have been identified .,A number of ARSA gene mutations responsible for [ MLD | Disease ] have been identified. ,O O O O O O O O B-Disease O O O O 
185,"Recently , the R496H mutation of ARSA was proposed to be a cause of MLD ( Draghia et al . , 1997 ) .","Recently, the R496H mutation of ARSA was proposed to be a cause of [ MLD | Disease ] ( Draghia et al., 1997 ). ",O O O O O O O O O O O O O O B-Disease O O O O O O O O O 
186,"We have investigated the R496H mutation and found this mutation at a relatively high frequency in an African American population ( f = 0 . 09 , n = 61 subjects ) .","We have investigated the R496H mutation and found this mutation at a relatively high frequency in an African American population ( f = 0. 09, n = 61 subjects ). ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
187,The ARSA enzyme activity in subjects with and without the R496H mutation was determined and found to be normal .,The ARSA enzyme activity in subjects with and without the R496H mutation was determined and found to be normal. ,O O O O O O O O O O O O O O O O O O O O 
188,It is therefore concluded that the R496H mutation of ARSA does not negatively influence the activity of ARSA and is not a cause of MLD,It is therefore concluded that the R496H mutation of ARSA does not negatively influence the activity of ARSA and is not a cause of [ MLD | Disease ] ,O O O O O O O O O O O O O O O O O O O O O O O O B-Disease 
189,Down - regulation of transmembrane carbonic anhydrases in renal cell carcinoma cell lines by wild - type von Hippel - Lindau transgenes .,Down - regulation of transmembrane carbonic anhydrases in   [ renal cell carcinoma | Disease ] cell lines by wild - type    [ von Hippel - Lindau | Disease ] transgenes. ,O O O O O O O O B-Disease I-Disease I-Disease O O O O O O B-Disease I-Disease I-Disease I-Disease O O 
190,"To discover genes involved in von Hippel - Lindau ( VHL ) - mediated carcinogenesis , we used renal cell carcinoma cell lines stably transfected with wild - type VHL - expressing transgenes .","To discover genes involved in    [ von Hippel - Lindau | Disease ] ( [ VHL | Disease ] ) - mediated carcinogenesis, we used   [ renal cell carcinoma | Disease ] cell lines stably transfected with wild - type VHL - expressing transgenes. ",O O O O O B-Disease I-Disease I-Disease I-Disease O B-Disease O O O O O O O B-Disease I-Disease I-Disease O O O O O O O O O O O O O 
191,"Large - scale RNA differential display technology applied to these cell lines identified several differentially expressed genes , including an alpha carbonic anhydrase gene , termed CA12 .","Large - scale RNA differential display technology applied to these cell lines identified several differentially expressed genes, including an alpha carbonic anhydrase gene, termed CA12. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
192,The deduced protein sequence was classified as a one - pass transmembrane CA possessing an apparently intact catalytic domain in the extracellular CA module .,The deduced protein sequence was classified as a one - pass transmembrane CA possessing an apparently intact catalytic domain in the extracellular CA module. ,O O O O O O O O O O O O O O O O O O O O O O O O O 
193,Reintroduced wild - type VHL strongly inhibited the overexpression of the CA12 gene in the parental renal cell carcinoma cell lines .,Reintroduced wild - type [ VHL | Disease ] strongly inhibited the overexpression of the CA12 gene in the parental   [ renal cell carcinoma | Disease ] cell lines. ,O O O O B-Disease O O O O O O O O O O O B-Disease I-Disease I-Disease O O O 
194,"Similar results were obtained with CA9 , encoding another transmembrane CA with an intact catalytic domain .","Similar results were obtained with CA9, encoding another transmembrane CA with an intact catalytic domain. ",O O O O O O O O O O O O O O O O O 
195,"Although both domains of the VHL protein contribute to regulation of CA12 expression , the elongin binding domain alone could effectively regulate CA9 expression .","Although both domains of the [ VHL | Disease ] protein contribute to regulation of CA12 expression, the elongin binding domain alone could effectively regulate CA9 expression. ",O O O O O B-Disease O O O O O O O O O O O O O O O O O O O 
196,We mapped CA12 and CA9 loci to chromosome bands 15q22 and 17q21 .,We mapped CA12 and CA9 loci to chromosome bands 15q22 and 17q21. ,O O O O O O O O O O O O O 
197,"2 respectively , regions prone to amplification in some human cancers .","2 respectively, regions prone to amplification in some human [ cancers | Disease ]. ",O O O O O O O O O O B-Disease O 
198,Additional experiments are needed to define the role of CA IX and CA XII enzymes in the regulation of pH in the extracellular microenvironment and its potential impact on cancer cell growth .,Additional experiments are needed to define the role of CA IX and CA XII enzymes in the regulation of pH in the extracellular microenvironment and its potential impact on [ cancer | Disease ] cell growth. ,O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease O O O 
199,A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy ( Wolfram syndrome ) .,A gene encoding a transmembrane protein is mutated in patients with  [ diabetes mellitus | Disease ] and  [ optic atrophy | Disease ] (  [ Wolfram syndrome | Disease ] ). ,O O O O O O O O O O O B-Disease I-Disease O B-Disease I-Disease O B-Disease I-Disease O O 
200,Wolfram syndrome ( WFS ; OMIM 222300 ) is an autosomal recessive neurodegenerative disorder defined by young - onset non - immune insulin - dependent diabetes mellitus and progressive optic atrophy ., [ Wolfram syndrome | Disease ] ( [ WFS | Disease ] ; OMIM 222300 ) is an    [ autosomal recessive neurodegenerative disorder | Disease ] defined by young - onset non - immune     [ insulin - dependent diabetes mellitus | Disease ] and progressive  [ optic atrophy | Disease ]. ,B-Disease I-Disease O B-Disease O O O O O O B-Disease I-Disease I-Disease I-Disease O O O O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease O O B-Disease I-Disease O 
201,Linkage to markers on chromosome 4p was confirmed in five families .,Linkage to markers on chromosome 4p was confirmed in five families. ,O O O O O O O O O O O O 
202,"On the basis of meiotic recombinants and disease - associated haplotypes , the WFS gene was localized to a BAC / P1 contig of less than 250 kb .","On the basis of meiotic recombinants and disease - associated haplotypes, the [ WFS | Disease ] gene was localized to a BAC / P1 contig of less than 250 kb. ",O O O O O O O O O O O O O B-Disease O O O O O O O O O O O O O O O 
203,"Mutations in a novel gene ( WFS1 ) encoding a putative transmembrane protein were found in all affected individuals in six WFS families , and these mutations were associated with the disease phenotype .","Mutations in a novel gene ( WFS1 ) encoding a putative transmembrane protein were found in all affected individuals in six [ WFS | Disease ] families, and these mutations were associated with the disease phenotype. ",O O O O O O O O O O O O O O O O O O O O O B-Disease O O O O O O O O O O O O 
204,WFS1 appears to function in survival of islet beta - cells and neurons . .,WFS1 appears to function in survival of islet beta - cells and neurons.. ,O O O O O O O O O O O O O O O 
205,Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells .,Stable interaction between the products of the BRCA1 and BRCA2 [ tumor | Disease ] suppressor genes in mitotic and meiotic cells. ,O O O O O O O O O O B-Disease O O O O O O O O 
206,"BRCA1 and BRCA2 account for most cases of familial , early onset breast and / or ovarian cancer and encode products that each interact with hRAD51 .","BRCA1 and BRCA2 account for most cases of familial, early onset      [ breast and / or ovarian cancer | Disease ] and encode products that each interact with hRAD51. ",O O O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O O O O O O O O O 
207,Results presented here show that BRCA1 and BRCA2 coexist in a biochemical complex and colocalize in subnuclear foci in somatic cells and on the axial elements of developing synaptonemal complexes .,Results presented here show that BRCA1 and BRCA2 coexist in a biochemical complex and colocalize in subnuclear foci in somatic cells and on the axial elements of developing synaptonemal complexes. ,O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
208,"Like BRCA1 and RAD51 , BRCA2 relocates to PCNA + replication sites following exposure of S phase cells to hydroxyurea or UV irradiation .","Like BRCA1 and RAD51, BRCA2 relocates to PCNA + replication sites following exposure of S phase cells to hydroxyurea or UV irradiation. ",O O O O O O O O O O O O O O O O O O O O O O O O 
209,"Thus , BRCA1 and BRCA2 participate , together , in a pathway ( s ) associated with the activation of double - strand break repair and / or homologous recombination .","Thus, BRCA1 and BRCA2 participate, together, in a pathway ( s ) associated with the activation of double - strand break repair and / or homologous recombination. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
210,Dysfunction of this pathway may be a general phenomenon in the majority of cases of hereditary breast and / or ovarian cancer . .,Dysfunction of this pathway may be a general phenomenon in the majority of cases of       [ hereditary breast and / or ovarian cancer | Disease ].. ,O O O O O O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O O 
211,A novel Arg362Ser mutation in the sterol 27 - hydroxylase gene ( CYP27 ) : its effects on pre - mRNA splicing and enzyme activity .,A novel Arg362Ser mutation in the sterol 27 - hydroxylase gene ( CYP27 ) : its effects on pre - mRNA splicing and enzyme activity. ,O O O O O O O O O O O O O O O O O O O O O O O O O O 
212,A novel C to A mutation in the sterol 27 - hydroxylase gene ( CYP27 ) was identified by sequencing amplified CYP27 gene products from a patient with cerebrotendinous xanthomatosis ( CTX ) .,A novel C to A mutation in the sterol 27 - hydroxylase gene ( CYP27 ) was identified by sequencing amplified CYP27 gene products from a patient with  [ cerebrotendinous xanthomatosis | Disease ] ( [ CTX | Disease ] ). ,O O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease I-Disease O B-Disease O O 
213,"The mutation changed the adrenodoxin cofactor binding residue 362Arg to 362Ser ( CGT 362Arg to AGT 362Ser ) , and was responsible for deficiency in the sterol 27 - hydroxylase activity , as confirmed by expression of mutant cDNA into COS - 1 cells .","The mutation changed the adrenodoxin cofactor binding residue 362Arg to 362Ser ( CGT 362Arg to AGT 362Ser ), and was responsible for deficiency in the sterol 27 - hydroxylase activity, as confirmed by expression of mutant cDNA into COS - 1 cells. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
214,Quantitative analysis showed that the expression of CYP27 gene mRNA in the patient represented 52 .,Quantitative analysis showed that the expression of CYP27 gene mRNA in the patient represented 52. ,O O O O O O O O O O O O O O O O 
215,5 % of the normal level .,5 % of the normal level. ,O O O O O O O 
216,"As the mutation occurred at the penultimate nucleotide of exon 6 ( - 2 position of exon 6 - intron 6 splice site ) of the gene , we hypothesized that the mutation may partially affect the normal splicing efficiency in exon 6 and cause alternative splicing elsewhere , which resulted in decreased transcript in the patient .","As the mutation occurred at the penultimate nucleotide of exon 6 ( - 2 position of exon 6 - intron 6 splice site ) of the gene, we hypothesized that the mutation may partially affect the normal splicing efficiency in exon 6 and cause alternative splicing elsewhere, which resulted in decreased transcript in the patient. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
217,"Transfection of constructed minigenes , with or without the mutation , into COS - 1 cells confirmed that the mutant minigene was responsible for a mRNA species alternatively spliced at an activated cryptic 5 splice site 88 bp upstream from the 3 end of exon 6 .","Transfection of constructed minigenes, with or without the mutation, into COS - 1 cells confirmed that the mutant minigene was responsible for a mRNA species alternatively spliced at an activated cryptic 5 splice site 88 bp upstream from the 3 end of exon 6. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
218,"Our data suggest that the C to A mutation at the penultimate nucleotide of exon 6 of the CYP27 gene not only causes the deficiency in the sterol 27 - hydroxylase activity , but also partially leads to alternative pre - mRNA splicing of the gene .","Our data suggest that the C to A mutation at the penultimate nucleotide of exon 6 of the CYP27 gene not only causes the        [ deficiency in the sterol 27 - hydroxylase activity | Disease ], but also partially leads to alternative pre - mRNA splicing of the gene. ",O O O O O O O O O O O O O O O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O O O O O O O O O O O O O O O 
219,"To our knowledge , this is the first report regarding effects on pre - mRNA splicing of a mutation at the - 2 position of a 5 splice site .","To our knowledge, this is the first report regarding effects on pre - mRNA splicing of a mutation at the - 2 position of a 5 splice site. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
220,ATM germline mutations in classical ataxia - telangiectasia patients in the Dutch population .,ATM germline mutations in classical   [ ataxia - telangiectasia | Disease ] patients in the Dutch population. ,O O O O O B-Disease I-Disease I-Disease O O O O O O 
221,Germline mutations in the ATM gene are responsible for the autosomal recessive disorder ataxia - telangiectasia ( A - T ) .,Germline mutations in the ATM gene are responsible for the   [ autosomal recessive disorder | Disease ]   [ ataxia - telangiectasia | Disease ] (   [ A - T | Disease ] ). ,O O O O O O O O O O B-Disease I-Disease I-Disease B-Disease I-Disease I-Disease O B-Disease I-Disease I-Disease O O 
222,"In our study , we have determined the ATM mutation spectrum in 19 classical A - T patients , including some immigrant populations , as well as 12 of Dutch ethnic origin .","In our study, we have determined the ATM mutation spectrum in 19 classical   [ A - T | Disease ] patients, including some immigrant populations, as well as 12 of Dutch ethnic origin. ",O O O O O O O O O O O O O O B-Disease I-Disease I-Disease O O O O O O O O O O O O O O O O 
223,"Both the protein truncation test ( PTT ) and the restriction endonuclease fingerprinting ( REF ) method were used and compared for their detection efficiency , identifying 76 % and 60 % of the mutations , respectively .","Both the protein truncation test ( PTT ) and the restriction endonuclease fingerprinting ( REF ) method were used and compared for their detection efficiency, identifying 76 % and 60 % of the mutations, respectively. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
224,Most patients were found to be compound heterozygote .,Most patients were found to be compound heterozygote. ,O O O O O O O O O 
225,"Seventeen mutations were distinct , of which 10 were not reported previously .","Seventeen mutations were distinct, of which 10 were not reported previously. ",O O O O O O O O O O O O O 
226,Mutations are small deletions or point mutations frequently affecting splice sites .,Mutations are small deletions or point mutations frequently affecting splice sites. ,O O O O O O O O O O O O 
227,"Moreover , a 16 .","Moreover, a 16. ",O O O O O 
228,"7 - kb genomic deletion of the 3 end of the gene , most likely a result of recombination between two LINE elements , was identified .","7 - kb genomic deletion of the 3 end of the gene, most likely a result of recombination between two LINE elements, was identified. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O 
229,"The most frequently found mutation , identified in three unrelated Turkish A - T individuals , was previously described to be a Turkish A - T founder mutation .","The most frequently found mutation, identified in three unrelated Turkish   [ A - T | Disease ] individuals, was previously described to be a Turkish   [ A - T | Disease ] founder mutation. ",O O O O O O O O O O O B-Disease I-Disease I-Disease O O O O O O O O O B-Disease I-Disease I-Disease O O O 
230,The presence of a founder mutation among relatively small ethnic population groups in Western Europe could indicate a high carrier frequency in such communities .,The presence of a founder mutation among relatively small ethnic population groups in Western Europe could indicate a high carrier frequency in such communities. ,O O O O O O O O O O O O O O O O O O O O O O O O O 
231,"In patients of Dutch ethnic origin , however , no significant founder effect could be identified .","In patients of Dutch ethnic origin, however, no significant founder effect could be identified. ",O O O O O O O O O O O O O O O O O 
232,The observed genetic heterogeneity including the relative high percentage of splice - site mutations had no reflection on the phenotype .,The observed genetic heterogeneity including the relative high percentage of splice - site mutations had no reflection on the phenotype. ,O O O O O O O O O O O O O O O O O O O O O 
233,All patients manifested classical A - T and increased cellular radioresistant DNA synthesis .,All patients manifested classical   [ A - T | Disease ] and increased cellular radioresistant DNA synthesis. ,O O O O B-Disease I-Disease I-Disease O O O O O O O 
234,Determination of the genomic structure of the COL4A4 gene and of novel mutations causing autosomal recessive Alport syndrome .,Determination of the genomic structure of the COL4A4 gene and of novel mutations causing    [ autosomal recessive Alport syndrome | Disease ]. ,O O O O O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease O 
235,"Autosomal recessive Alport syndrome is a progressive hematuric glomerulonephritis characterized by glomerular basement membrane abnormalities and associated with mutations in either the COL4A3 or the COL4A4 gene , which encode the alpha3 and alpha4 type IV collagen chains , respectively .","   [ Autosomal recessive Alport syndrome | Disease ] is a progressive  [ hematuric glomerulonephritis | Disease ] characterized by    [ glomerular basement membrane abnormalities | Disease ] and associated with mutations in either the COL4A3 or the COL4A4 gene, which encode the alpha3 and alpha4 type IV collagen chains, respectively. ",B-Disease I-Disease I-Disease I-Disease O O O B-Disease I-Disease O O B-Disease I-Disease I-Disease I-Disease O O O O O O O O O O O O O O O O O O O O O O O O O O 
236,"To date , mutation screening in the two genes has been hampered by the lack of genomic structure information .","To date, mutation screening in the two genes has been hampered by the lack of genomic structure information. ",O O O O O O O O O O O O O O O O O O O O 
237,"We report here the complete characterization of the 48 exons of the COL4A4 gene , a comprehensive gene screen , and the subsequent detection of 10 novel mutations in eight patients diagnosed with autosomal recessive Alport syndrome .","We report here the complete characterization of the 48 exons of the COL4A4 gene, a comprehensive gene screen, and the subsequent detection of 10 novel mutations in eight patients diagnosed with    [ autosomal recessive Alport syndrome | Disease ]. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease O 
238,"Furthermore , we identified a glycine to alanine substitution in the collagenous domain that is apparently silent in the heterozygous carriers , in 11 .","Furthermore, we identified a glycine to alanine substitution in the collagenous domain that is apparently silent in the heterozygous carriers, in 11. ",O O O O O O O O O O O O O O O O O O O O O O O O O 
239,"5 % of all control individuals , and in one control individual homozygous for this glycine substitution .","5 % of all control individuals, and in one control individual homozygous for this glycine substitution. ",O O O O O O O O O O O O O O O O O O 
240,There has been no previous finding of a glycine substitution that is not associated with any obvious phenotype in homozygous individuals .,There has been no previous finding of a glycine substitution that is not associated with any obvious phenotype in homozygous individuals. ,O O O O O O O O O O O O O O O O O O O O O O 
241,Founder BRCA1 and BRCA2 mutations in French Canadian breast and ovarian cancer families .,Founder BRCA1 and BRCA2 mutations in French Canadian    [ breast and ovarian cancer | Disease ] families. ,O O O O O O O O B-Disease I-Disease I-Disease I-Disease O O 
242,"We have identified four mutations in each of the breast cancer - susceptibility genes , BRCA1 and BRCA2 , in French Canadian breast cancer and breast / ovarian cancer families from Quebec .","We have identified four mutations in each of the  [ breast cancer | Disease ] - susceptibility genes, BRCA1 and BRCA2, in French Canadian  [ breast cancer | Disease ] and    [ breast / ovarian cancer | Disease ] families from Quebec. ",O O O O O O O O O B-Disease I-Disease O O O O O O O O O O O B-Disease I-Disease O B-Disease I-Disease I-Disease I-Disease O O O O 
243,"To identify founder effects , we examined independently ascertained French Canadian cancer families for the distribution of these eight mutations .","To identify founder effects, we examined independently ascertained French Canadian [ cancer | Disease ] families for the distribution of these eight mutations. ",O O O O O O O O O O O B-Disease O O O O O O O O O 
244,Mutations were found in 41 of 97 families .,Mutations were found in 41 of 97 families. ,O O O O O O O O O 
245,Six of eight mutations were observed at least twice .,Six of eight mutations were observed at least twice. ,O O O O O O O O O O 
246,"The BRCA1 C4446T mutation was the most common mutation found , followed by the BRCA2 8765delAG mutation .","The BRCA1 C4446T mutation was the most common mutation found, followed by the BRCA2 8765delAG mutation. ",O O O O O O O O O O O O O O O O O O 
247,"Together , these mutations were found in 28 of 41 families identified to have a mutation .","Together, these mutations were found in 28 of 41 families identified to have a mutation. ",O O O O O O O O O O O O O O O O O 
248,The odds of detection of any of the four BRCA1 mutations was 18 .,The odds of detection of any of the four BRCA1 mutations was 18. ,O O O O O O O O O O O O O O 
249,7x greater if one or more cases of ovarian cancer were also present in the family .,7x greater if one or more cases of  [ ovarian cancer | Disease ] were also present in the family. ,O O O O O O O O B-Disease I-Disease O O O O O O O 
250,The odds of detection of any of the four BRCA2 mutations was 5 .,The odds of detection of any of the four BRCA2 mutations was 5. ,O O O O O O O O O O O O O O 
251,3x greater if there were at least five cases of breast cancer in the family .,3x greater if there were at least five cases of  [ breast cancer | Disease ] in the family. ,O O O O O O O O O O B-Disease I-Disease O O O O 
252,"Interestingly , the presence of a breast cancer case < 36 years of age was strongly predictive of the presence of any of the eight mutations screened .","Interestingly, the presence of a  [ breast cancer | Disease ] case < 36 years of age was strongly predictive of the presence of any of the eight mutations screened. ",O O O O O O B-Disease I-Disease O O O O O O O O O O O O O O O O O O O O 
253,"Carriers of the same mutation , from different families , shared similar haplotypes , indicating that the mutant alleles were likely to be identical by descent for a mutation in the founder population .","Carriers of the same mutation, from different families, shared similar haplotypes, indicating that the mutant alleles were likely to be identical by descent for a mutation in the founder population. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
254,The identification of common BRCA1 and BRCA2 mutations will facilitate carrier detection in French Canadian breast cancer and breast / ovarian cancer families .,The identification of common BRCA1 and BRCA2 mutations will facilitate carrier detection in French Canadian  [ breast cancer | Disease ] and    [ breast / ovarian cancer | Disease ] families. ,O O O O O O O O O O O O O O O B-Disease I-Disease O B-Disease I-Disease I-Disease I-Disease O O 
255,Are Dp71 and Dp140 brain dystrophin isoforms related to cognitive impairment in Duchenne muscular dystrophy ?,Are Dp71 and Dp140 brain dystrophin isoforms related to  [ cognitive impairment | Disease ] in   [ Duchenne muscular dystrophy | Disease ] ? ,O O O O O O O O O B-Disease I-Disease O B-Disease I-Disease I-Disease O 
256,Molecular study and neuropsychological analysis were performed concurrently on 49 patients with Duchenne muscular dystrophy ( DMD ) in order to find a molecular explanation for the cognitive impairment observed in most DMD patients .,Molecular study and neuropsychological analysis were performed concurrently on 49 patients with   [ Duchenne muscular dystrophy | Disease ] ( [ DMD | Disease ] ) in order to find a molecular explanation for the  [ cognitive impairment | Disease ] observed in most [ DMD | Disease ] patients. ,O O O O O O O O O O O O B-Disease I-Disease I-Disease O B-Disease O O O O O O O O O O B-Disease I-Disease O O O B-Disease O O 
257,Complete analysis of the dystrophin gene was performed to define the localization of deletions and duplications in relation to the different DMD promoters .,Complete analysis of the dystrophin gene was performed to define the localization of deletions and duplications in relation to the different [ DMD | Disease ] promoters. ,O O O O O O O O O O O O O O O O O O O O O B-Disease O O 
258,Qualitative analysis of the Dp71 transcript and testing for the specific first exon of Dp140 were also carried out .,Qualitative analysis of the Dp71 transcript and testing for the specific first exon of Dp140 were also carried out. ,O O O O O O O O O O O O O O O O O O O O 
259,"Neuropsychological analysis assessed verbal and visuospatial intelligence , verbal memory , and reading skills .","Neuropsychological analysis assessed verbal and visuospatial intelligence, verbal memory, and reading skills. ",O O O O O O O O O O O O O O O 
260,Comparison of molecular and psychometric findings demonstrated that deletions and duplications that were localized in the distal part of the gene seemed to be preferentially associated with cognitive impairment .,Comparison of molecular and psychometric findings demonstrated that deletions and duplications that were localized in the distal part of the gene seemed to be preferentially associated with  [ cognitive impairment | Disease ]. ,O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease I-Disease O 
261,Two altered Dp71 transcripts and two deleted Dp140 DNA sequences were found in four patients with severe cerebral dysfunction .,Two altered Dp71 transcripts and two deleted Dp140 DNA sequences were found in four patients with severe  [ cerebral dysfunction | Disease ]. ,O O O O O O O O O O O O O O O O O B-Disease I-Disease O 
262,"These findings suggest that some sequences located in the distal part of the gene and , in particular , some DMD isoforms expressed in the brain may be related to the cognitive impairment associated with DMD . .","These findings suggest that some sequences located in the distal part of the gene and, in particular, some [ DMD | Disease ] isoforms expressed in the brain may be related to the  [ cognitive impairment | Disease ] associated with [ DMD | Disease ].. ",O O O O O O O O O O O O O O O O O O O O B-Disease O O O O O O O O O O B-Disease I-Disease O O B-Disease O O 
263,I1307K APC and hMLH1 mutations in a non - Jewish family with hereditary non - polyposis colorectal cancer .,I1307K APC and hMLH1 mutations in a non - Jewish family with      [ hereditary non - polyposis colorectal cancer | Disease ]. ,O O O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O 
264,We describe a French Canadian hereditary non - polyposis colorectal cancer ( HNPCC ) kindred which carries a novel truncating mutation in hMLH1 .,We describe a French Canadian      [ hereditary non - polyposis colorectal cancer | Disease ] ( [ HNPCC | Disease ] ) kindred which carries a novel truncating mutation in hMLH1. ,O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O B-Disease O O O O O O O O O O O 
265,"Interestingly , the I1307K APC polymorphism , associated with an increased risk of colorectal cancer , is also present in this family .","Interestingly, the I1307K APC polymorphism, associated with an increased risk of  [ colorectal cancer | Disease ], is also present in this family. ",O O O O O O O O O O O O O B-Disease I-Disease O O O O O O O O 
266,The I1307K polymorphism has previously only been identified in individuals of self - reported Ashkenazi Jewish origins .,The I1307K polymorphism has previously only been identified in individuals of self - reported Ashkenazi Jewish origins. ,O O O O O O O O O O O O O O O O O O 
267,"In addition , in this family , there appears to be no relationship between the I1307K polymorphism and the presence or absence of cancer . .","In addition, in this family, there appears to be no relationship between the I1307K polymorphism and the presence or absence of [ cancer | Disease ].. ",O O O O O O O O O O O O O O O O O O O O O O O B-Disease O O 
268,Identification of a novel mutation of the CPO gene in a Japanese hereditary coproporphyria family .,Identification of a novel mutation of the CPO gene in a Japanese  [ hereditary coproporphyria | Disease ] family. ,O O O O O O O O O O O O B-Disease I-Disease O O 
269,Hereditary coproporphyria ( HCP ) is an autosomal dominant disease characterized by a deficiency of coproporphyrinogen oxidase ( CPO ) caused by a mutation in the CPO gene ., [ Hereditary coproporphyria | Disease ] ( [ HCP | Disease ] ) is an   [ autosomal dominant disease | Disease ] characterized by a    [ deficiency of coproporphyrinogen oxidase | Disease ] ( CPO ) caused by a mutation in the CPO gene. ,B-Disease I-Disease O B-Disease O O O B-Disease I-Disease I-Disease O O O B-Disease I-Disease I-Disease I-Disease O O O O O O O O O O O O 
270,Only 11 mutations of the gene have been reported in HCP patients .,Only 11 mutations of the gene have been reported in [ HCP | Disease ] patients. ,O O O O O O O O O O B-Disease O O 
271,We report another mutation in a Japanese family .,We report another mutation in a Japanese family. ,O O O O O O O O O 
272,"Polymerase chain reaction - single strand conformational polymorphism and direct sequence analyses demonstrated a C to T substitution in exon 1 of the CPO gene at nucleotide position 85 , which lies in the putative presequence for targeting to mitochondria .","Polymerase chain reaction - single strand conformational polymorphism and direct sequence analyses demonstrated a C to T substitution in exon 1 of the CPO gene at nucleotide position 85, which lies in the putative presequence for targeting to mitochondria. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
273,This mutation changes the codon for glutamine to a termination codon at amino acid position 29 .,This mutation changes the codon for glutamine to a termination codon at amino acid position 29. ,O O O O O O O O O O O O O O O O O 
274,MaeI restriction analysis showed two other carriers in the family .,MaeI restriction analysis showed two other carriers in the family. ,O O O O O O O O O O O 
275,"The C - T mutation is located within a recently proposed putative alternative translation initiation codon ( TIC - 1 ) , supporting that TIC - 1 is the real TIC rather than TIC - 2 . .","The C - T mutation is located within a recently proposed putative alternative translation initiation codon ( TIC - 1 ), supporting that TIC - 1 is the real TIC rather than TIC - 2.. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
276,Human complement factor H deficiency associated with hemolytic uremic syndrome .,    [ Human complement factor H deficiency | Disease ] associated with   [ hemolytic uremic syndrome | Disease ]. ,B-Disease I-Disease I-Disease I-Disease I-Disease O O B-Disease I-Disease I-Disease O 
277,This study reports on six cases of deficiency in the human complement regulatory protein Factor H ( FH ) in the context of an acute renal disease .,This study reports on six cases of         [ deficiency in the human complement regulatory protein Factor H | Disease ] ( FH ) in the context of an   [ acute renal disease | Disease ]. ,O O O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O O O O O O O O B-Disease I-Disease I-Disease O 
278,Five of the cases were observed in children presenting with idiopathic hemolytic uremic syndrome ( HUS ) .,Five of the cases were observed in children presenting with idiopathic   [ hemolytic uremic syndrome | Disease ] ( [ HUS | Disease ] ). ,O O O O O O O O O O O B-Disease I-Disease I-Disease O B-Disease O O 
279,"Two of the children exhibited a homozygous deficiency characterized by the absence of the 150 - kD form of Factor H and the presence , upon immunoblotting , of the 42 - kD Factor H - like protein 1 ( FHL - 1 ) and other FH - related protein ( FHR ) bands .","Two of the children exhibited a homozygous deficiency characterized by the absence of the 150 - kD form of Factor H and the presence, upon immunoblotting, of the 42 - kD Factor H - like protein 1 ( FHL - 1 ) and other FH - related protein ( FHR ) bands. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
280,Southern blot and PCR analysis of DNA of one patient with homozygous deficiency ruled out the presence of a large deletion of the FH gene as the underlying defect for the deficiency .,Southern blot and PCR analysis of DNA of one patient with homozygous deficiency ruled out the presence of a large deletion of the FH gene as the underlying defect for the deficiency. ,O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
281,The other four children presented with heterozygous deficiency and exhibited a normal immunoblotting pattern of proteins of the FH family .,The other four children presented with heterozygous deficiency and exhibited a normal immunoblotting pattern of proteins of the FH family. ,O O O O O O O O O O O O O O O O O O O O O 
282,Factor H deficiency is the only complement deficiency associated with HUS .,  [ Factor H deficiency | Disease ] is the only  [ complement deficiency | Disease ] associated with [ HUS | Disease ]. ,B-Disease I-Disease I-Disease O O O B-Disease I-Disease O O B-Disease O 
283,These observations suggest a role for FH and / or FH receptors in the pathogenesis of idiopathic HUS . .,These observations suggest a role for FH and / or FH receptors in the pathogenesis of idiopathic [ HUS | Disease ].. ,O O O O O O O O O O O O O O O O O B-Disease O O 
284,Further evidence for a major ancient mutation underlying myotonic dystrophy from linkage disequilibrium studies in the Japanese population .,Further evidence for a major ancient mutation underlying  [ myotonic dystrophy | Disease ] from linkage disequilibrium studies in the Japanese population. ,O O O O O O O O B-Disease I-Disease O O O O O O O O O 
285,"The myotonic dystrophy ( DM ) mutation is an unstable ( CTG ) n repeat , present at a copy number of 5 - 37 repeats on normal chromosomes but amplified to 50 - 3000 copies on DM chromosomes .","The  [ myotonic dystrophy | Disease ] ( [ DM | Disease ] ) mutation is an unstable ( CTG ) n repeat, present at a copy number of 5 - 37 repeats on normal chromosomes but amplified to 50 - 3000 copies on [ DM | Disease ] chromosomes. ",O B-Disease I-Disease O B-Disease O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease O O 
286,Previous findings in Caucasian populations of a DM founder chromosome raise a question about the molecular events involved in the expansion mutation .,Previous findings in Caucasian populations of a [ DM | Disease ] founder chromosome raise a question about the molecular events involved in the expansion mutation. ,O O O O O O O B-Disease O O O O O O O O O O O O O O O 
287,"To investigate whether a founder chromosome for the DM mutation exists in the Japanese population , we genotyped families using polymorphic markers near the ( CTG ) n repeat region and constructed haplotypes .","To investigate whether a founder chromosome for the [ DM | Disease ] mutation exists in the Japanese population, we genotyped families using polymorphic markers near the ( CTG ) n repeat region and constructed haplotypes. ",O O O O O O O O B-Disease O O O O O O O O O O O O O O O O O O O O O O O O O 
288,Six different haplotypes were found and DM alleles were always haplotype A .,Six different haplotypes were found and [ DM | Disease ] alleles were always haplotype A. ,O O O O O O B-Disease O O O O O O 
289,To find an origin of the ( CTG ) n repeat mutation and to investigate the mechanism of the expansion mutation in the Japanese population we have studied 90 Japanese DM families comprising 190 affected and 130 unaffected members .,To find an origin of the ( CTG ) n repeat mutation and to investigate the mechanism of the expansion mutation in the Japanese population we have studied 90 Japanese [ DM | Disease ] families comprising 190 affected and 130 unaffected members. ,O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease O O O O O O O O O 
290,The results suggest that a few common ancestral mutations in both Caucasian and Japanese populations have originated by expansion of an ancestral n = 5 repeat to n = 19 - 37 copies .,The results suggest that a few common ancestral mutations in both Caucasian and Japanese populations have originated by expansion of an ancestral n = 5 repeat to n = 19 - 37 copies. ,O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
291,These data support multistep models of triplet repeat expansion that have been proposed for both DM and Friedreichs ataxia . .,These data support multistep models of triplet repeat expansion that have been proposed for both [ DM | Disease ] and  [ Friedreichs ataxia | Disease ].. ,O O O O O O O O O O O O O O O B-Disease O B-Disease I-Disease O O 
292,"The molecular basis of C6 deficiency in the western Cape , South Africa .","The molecular basis of  [ C6 deficiency | Disease ] in the western Cape, South Africa. ",O O O O B-Disease I-Disease O O O O O O O O 
293,"Deficiency of the sixth component of human complement ( C6 ) has been reported in a number of families from the western Cape , South Africa .","       [ Deficiency of the sixth component of human complement | Disease ] ( C6 ) has been reported in a number of families from the western Cape, South Africa. ",B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O O O O O O O O O O O O O O O O O O O 
294,Meningococcal disease is endemic in the Cape and almost all pedigrees of total C6 deficiency ( C6Q0 ) have been ascertained because of recurrent disease ., [ Meningococcal disease | Disease ] is endemic in the Cape and almost all pedigrees of total  [ C6 deficiency | Disease ] ( C6Q0 ) have been ascertained because of recurrent disease. ,B-Disease I-Disease O O O O O O O O O O O B-Disease I-Disease O O O O O O O O O O O 
295,"We have sequenced the expressed exons of the C6 gene from selected cases and have found three molecular defects leading to total deficiency 879delG , which is the common defect in the Cape and hitherto unreported , and 1195delC and 1936delG , which have been previously reported in African - Americans .","We have sequenced the expressed exons of the C6 gene from selected cases and have found three molecular defects leading to total deficiency 879delG, which is the common defect in the Cape and hitherto unreported, and 1195delC and 1936delG, which have been previously reported in African - Americans. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
296,"We also show that the 879delG and 1195delC defects are associated with characteristic C6 / C7 region DNA marker haplotypes , although small variations were observed .","We also show that the 879delG and 1195delC defects are associated with characteristic C6 / C7 region DNA marker haplotypes, although small variations were observed. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O 
297,"The 1936delG defect was observed only once in the Cape , but its associated haplotype could be deduced .","The 1936delG defect was observed only once in the Cape, but its associated haplotype could be deduced. ",O O O O O O O O O O O O O O O O O O O 
298,The data from the haplotypes indicate that these three molecular defects account for the defects in all the 38 unrelated C6Q0 individuals we have studied from the Cape .,The data from the haplotypes indicate that these three molecular defects account for the defects in all the 38 unrelated C6Q0 individuals we have studied from the Cape. ,O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
299,"We have also observed the 879delG defect in two Dutch C6 - deficient kindreds , but the 879delG defect in the Cape probably did not come from The Netherlands . .","We have also observed the 879delG defect in two Dutch   [ C6 - deficient | Disease ] kindreds, but the 879delG defect in the Cape probably did not come from The Netherlands.. ",O O O O O O O O O O B-Disease I-Disease I-Disease O O O O O O O O O O O O O O O O O O 
300,Complement C7 deficiency : seven further molecular defects and their associated marker haplotypes .,  [ Complement C7 deficiency | Disease ] : seven further molecular defects and their associated marker haplotypes. ,B-Disease I-Disease I-Disease O O O O O O O O O O O 
301,Seven further molecular bases of C7 deficiency are described .,Seven further molecular bases of  [ C7 deficiency | Disease ] are described. ,O O O O O B-Disease I-Disease O O O 
302,"All these new molecular defects involve single - nucleotide events , deletions and substitutions , some of which alter splice sites , and others codons .","All these new molecular defects involve single - nucleotide events, deletions and substitutions, some of which alter splice sites, and others codons. ",O O O O O O O O O O O O O O O O O O O O O O O O O O 
303,"They are distributed along the C7 gene , but predominantly towards the 3 end .","They are distributed along the C7 gene, but predominantly towards the 3 end. ",O O O O O O O O O O O O O O O 
304,All were found in compound heterozygous individuals .,All were found in compound heterozygous individuals. ,O O O O O O O O 
305,The C6 / C7 marker haplotypes associated with most C7 defects are tabulated . .,The C6 / C7 marker haplotypes associated with most  [ C7 defects | Disease ] are tabulated.. ,O O O O O O O O O B-Disease I-Disease O O O O 
306,A genome - wide search for chromosomal loci linked to mental health wellness in relatives at high risk for bipolar affective disorder among the Old Order Amish .,A genome - wide search for chromosomal loci linked to mental health wellness in relatives at high risk for   [ bipolar affective disorder | Disease ] among the Old Order Amish. ,O O O O O O O O O O O O O O O O O O O B-Disease I-Disease I-Disease O O O O O O 
307,Bipolar affective disorder ( BPAD ; manic - depressive illness ) is characterized by episodes of mania and / or hypomania interspersed with periods of depression .,  [ Bipolar affective disorder | Disease ] ( [ BPAD | Disease ] ;    [ manic - depressive illness | Disease ] ) is characterized by episodes of [ mania | Disease ] and / or [ hypomania | Disease ] interspersed with periods of [ depression | Disease ]. ,B-Disease I-Disease I-Disease O B-Disease O B-Disease I-Disease I-Disease I-Disease O O O O O O B-Disease O O O B-Disease O O O O B-Disease O 
308,Compelling evidence supports a significant genetic component in the susceptibility to develop BPAD .,Compelling evidence supports a significant genetic component in the susceptibility to develop [ BPAD | Disease ]. ,O O O O O O O O O O O O B-Disease O 
309,"To date , however , linkage studies have attempted only to identify chromosomal loci that cause or increase the risk of developing BPAD .","To date, however, linkage studies have attempted only to identify chromosomal loci that cause or increase the risk of developing [ BPAD | Disease ]. ",O O O O O O O O O O O O O O O O O O O O O O B-Disease O 
310,"To determine whether there could be protective alleles that prevent or reduce the risk of developing BPAD , similar to what is observed in other genetic disorders , we used mental health wellness ( absence of any psychiatric disorder ) as the phenotype in our genome - wide linkage scan of several large multigeneration Old Order Amish pedigrees exhibiting an extremely high incidence of BPAD .","To determine whether there could be protective alleles that prevent or reduce the risk of developing [ BPAD | Disease ], similar to what is observed in other  [ genetic disorders | Disease ], we used mental health wellness ( absence of any  [ psychiatric disorder | Disease ] ) as the phenotype in our genome - wide linkage scan of several large multigeneration Old Order Amish pedigrees exhibiting an extremely high incidence of [ BPAD | Disease ]. ",O O O O O O O O O O O O O O O O B-Disease O O O O O O O O B-Disease I-Disease O O O O O O O O O O B-Disease I-Disease O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease O 
311,"We have found strong evidence for a locus on chromosome 4p at D4S2949 ( maximum GENEHUNTER - PLUS nonparametric linkage score = 4 . 05 , P = 5 . 22 x 10 ( - 4 ) ; SIBPAL Pempirical value < 3 x 10 ( - 5 ) ) and suggestive evidence for a locus on chromosome 4q at D4S397 ( maximum GENEHUNTER - PLUS nonparametric linkage score = 3 . 29 , P = 2 . 57 x 10 ( - 3 ) ; SIBPAL Pempirical value < 1 x 10 ( - 3 ) ) that are linked to mental health wellness .","We have found strong evidence for a locus on chromosome 4p at D4S2949 ( maximum GENEHUNTER - PLUS nonparametric linkage score = 4. 05, P = 5. 22 x 10 ( - 4 ) ; SIBPAL Pempirical value < 3 x 10 ( - 5 ) ) and suggestive evidence for a locus on chromosome 4q at D4S397 ( maximum GENEHUNTER - PLUS nonparametric linkage score = 3. 29, P = 2. 57 x 10 ( - 3 ) ; SIBPAL Pempirical value < 1 x 10 ( - 3 ) ) that are linked to mental health wellness. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
312,These findings are consistent with the hypothesis that certain alleles could prevent or modify the clinical manifestations of BPAD and perhaps other related affective disorders .,These findings are consistent with the hypothesis that certain alleles could prevent or modify the clinical manifestations of [ BPAD | Disease ] and perhaps other related  [ affective disorders | Disease ]. ,O O O O O O O O O O O O O O O O O O B-Disease O O O O B-Disease I-Disease O 
313,Segregation distortion in myotonic dystrophy .,Segregation distortion in  [ myotonic dystrophy | Disease ]. ,O O O B-Disease I-Disease O 
314,"Myotonic dystrophy ( DM ) is an autosomal dominant disease which , in the typical pedigree , shows a three generation anticipation cascade ."," [ Myotonic dystrophy | Disease ] ( [ DM | Disease ] ) is an   [ autosomal dominant disease | Disease ] which, in the typical pedigree, shows a three generation anticipation cascade. ",B-Disease I-Disease O B-Disease O O O B-Disease I-Disease I-Disease O O O O O O O O O O O O O O 
315,This results in infertility and congenital myotonic dystrophy ( CDM ) with the disappearance of DM in that pedigree .,This results in [ infertility | Disease ] and   [ congenital myotonic dystrophy | Disease ] ( [ CDM | Disease ] ) with the disappearance of [ DM | Disease ] in that pedigree. ,O O O B-Disease O B-Disease I-Disease I-Disease O B-Disease O O O O O B-Disease O O O O 
316,"The concept of segregation distortion , where there is preferential transmission of the larger allele at the DM locus , has been put forward to explain partially the maintenance of DM in the population .","The concept of segregation distortion, where there is preferential transmission of the larger allele at the [ DM | Disease ] locus, has been put forward to explain partially the maintenance of [ DM | Disease ] in the population. ",O O O O O O O O O O O O O O O O O B-Disease O O O O O O O O O O O O B-Disease O O O O 
317,"In a survey of DM in Northern Ireland , 59 pedigrees were ascertained .","In a survey of [ DM | Disease ] in Northern Ireland, 59 pedigrees were ascertained. ",O O O O B-Disease O O O O O O O O O 
318,Sibships where the status of all the members had been identified were examined to determine the transmission of the DM expansion from affected parents to their offspring .,Sibships where the status of all the members had been identified were examined to determine the transmission of the [ DM | Disease ] expansion from affected parents to their offspring. ,O O O O O O O O O O O O O O O O O O O B-Disease O O O O O O O O 
319,"Where the transmitting parent was male , 58 .","Where the transmitting parent was male, 58. ",O O O O O O O O O 
320,"3 % of the offspring were affected , and in the case of a female transmitting parent , 68 .","3 % of the offspring were affected, and in the case of a female transmitting parent, 68. ",O O O O O O O O O O O O O O O O O O O O 
321,7 % were affected .,7 % were affected. ,O O O O O 
322,Studies on meiotic drive in DM have shown increased transmission of the larger allele at the DM locus in non - DM heterozygotes for CTGn .,Studies on meiotic drive in [ DM | Disease ] have shown increased transmission of the larger allele at the [ DM | Disease ] locus in non - DM heterozygotes for CTGn. ,O O O O O B-Disease O O O O O O O O O O B-Disease O O O O O O O O O 
323,This study provides further evidence that the DM expansion tends to be transmitted preferentially .,This study provides further evidence that the [ DM | Disease ] expansion tends to be transmitted preferentially. ,O O O O O O O B-Disease O O O O O O O 
324,Diagnosis of hemochromatosis .,Diagnosis of [ hemochromatosis | Disease ]. ,O O B-Disease O 
325,"If untreated , hemochromatosis can cause serious illness and early death , but the disease is still substantially under - diagnosed .","If untreated, [ hemochromatosis | Disease ] can cause serious illness and  [ early death | Disease ], but the disease is still substantially under - diagnosed. ",O O O B-Disease O O O O O B-Disease I-Disease O O O O O O O O O O O 
326,The cornerstone of screening and case detection is the measurement of serum transferrin saturation and the serum ferritin level .,The cornerstone of screening and case detection is the measurement of serum transferrin saturation and the serum ferritin level. ,O O O O O O O O O O O O O O O O O O O O 
327,"Once the diagnosis is suspected , physicians must use serum ferritin levels and hepatic iron stores on liver biopsy specimens to assess patients for the presence of iron overload .","Once the diagnosis is suspected, physicians must use serum ferritin levels and hepatic iron stores on liver biopsy specimens to assess patients for the presence of  [ iron overload | Disease ]. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease I-Disease O 
328,"Liver biopsy is also used to establish the presence or absence of cirrhosis , which can affect prognosis and management .","Liver biopsy is also used to establish the presence or absence of [ cirrhosis | Disease ], which can affect prognosis and management. ",O O O O O O O O O O O O B-Disease O O O O O O O O 
329,"A DNA - based test for the HFE gene is commercially available , but its place in the diagnosis of hemochromatosis is still being evaluated .","A DNA - based test for the HFE gene is commercially available, but its place in the diagnosis of [ hemochromatosis | Disease ] is still being evaluated. ",O O O O O O O O O O O O O O O O O O O O B-Disease O O O O O 
330,"Currently , the most useful role for this test is in the detection of hemochromatosis in the family members of patients with a proven case of the disease .","Currently, the most useful role for this test is in the detection of [ hemochromatosis | Disease ] in the family members of patients with a proven case of the disease. ",O O O O O O O O O O O O O O B-Disease O O O O O O O O O O O O O O 
331,It is crucial to diagnose hemochromatosis before hepatic cirrhosis develops because phlebotomy therapy can avert serious chronic disease and can even lead to normal life expectancy . .,It is crucial to diagnose [ hemochromatosis | Disease ] before  [ hepatic cirrhosis | Disease ] develops because phlebotomy therapy can avert serious chronic disease and can even lead to normal life expectancy.. ,O O O O O B-Disease O B-Disease I-Disease O O O O O O O O O O O O O O O O O O O 
332,Prevalence of the I1307K APC gene variant in Israeli Jews of differing ethnic origin and risk for colorectal cancer .,Prevalence of the I1307K [ APC | Disease ] gene variant in Israeli Jews of differing ethnic origin and risk for  [ colorectal cancer | Disease ]. ,O O O O B-Disease O O O O O O O O O O O O B-Disease I-Disease O 
333,"BACKGROUND & AIMS Israeli Jews of European birth , i . e . , Ashkenazim , have the highest colorectal cancer incidence of any Israeli ethnic group .","BACKGROUND & AIMS Israeli Jews of European birth, i. e., Ashkenazim, have the highest  [ colorectal cancer | Disease ] incidence of any Israeli ethnic group. ",O O O O O O O O O O O O O O O O O O O B-Disease I-Disease O O O O O O O 
334,The I1307K APC gene variant was found in 6 .,The I1307K [ APC | Disease ] gene variant was found in 6. ,O O B-Disease O O O O O O O 
335,"1 % of American Jews , 28 % of their familial colorectal cancer cases , but not in non - Jews .","1 % of American Jews, 28 % of their familial  [ colorectal cancer | Disease ] cases, but not in non - Jews. ",O O O O O O O O O O O B-Disease I-Disease O O O O O O O O O 
336,We assessed the I1307K prevalence in Israeli Jews of differing ethnic origin and risk for colorectal cancer .,We assessed the I1307K prevalence in Israeli Jews of differing ethnic origin and risk for  [ colorectal cancer | Disease ]. ,O O O O O O O O O O O O O O O B-Disease I-Disease O 
337,"METHODS DNA samples from 500 unrelated Jews of European or non - European origin , with or without a personal and / or family history of neoplasia , were examined for the I1307K variant by the allele - specific oligonucleotide ( ASO ) method .","METHODS DNA samples from 500 unrelated Jews of European or non - European origin, with or without a personal and / or family history of [ neoplasia | Disease ], were examined for the I1307K variant by the allele - specific oligonucleotide ( ASO ) method. ",O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease O O O O O O O O O O O O O O O O O O 
338,"RESULTS In persons at average risk for colorectal cancer , I1307K was found in 5 .","RESULTS In persons at average risk for  [ colorectal cancer | Disease ], I1307K was found in 5. ",O O O O O O O B-Disease I-Disease O O O O O O O 
339,0 % of 120 European and 1 .,0 % of 120 European and 1. ,O O O O O O O O 
340,6 % of 188 non - European Jews ( P = 0 . 08 ) .,6 % of 188 non - European Jews ( P = 0. 08 ). ,O O O O O O O O O O O O O O O O 
341,It occurred in 15 .,It occurred in 15. ,O O O O O 
342,4 % of 52 Ashkenazi Israelis with familial cancer ( P = 0 . 02 ) and was not detected in 51 non - European Jews at increased cancer risk .,4 % of 52 Ashkenazi Israelis with familial [ cancer | Disease ] ( P = 0. 02 ) and was not detected in 51 non - European Jews at increased [ cancer | Disease ] risk. ,O O O O O O O O B-Disease O O O O O O O O O O O O O O O O O O O B-Disease O O 
343,"Colorectal neoplasia occurred personally or in the families of 13 of 20 Ashkenazi I1307K carriers , 8 of whom also had a personal or family history of noncolonic neoplasia ."," [ Colorectal neoplasia | Disease ] occurred personally or in the families of 13 of 20 Ashkenazi I1307K carriers, 8 of whom also had a personal or family history of noncolonic [ neoplasia | Disease ]. ",B-Disease I-Disease O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease O 
344,"CONCLUSIONS The I1307K APC variant may represent a susceptibility gene for colorectal , or other , cancers in Ashkenazi Jews , and partially explains the higher incidence of colorectal cancer in European Israelis .","CONCLUSIONS The I1307K APC variant may represent a susceptibility gene for      [ colorectal , or other , cancers | Disease ] in Ashkenazi Jews, and partially explains the higher incidence of  [ colorectal cancer | Disease ] in European Israelis. ",O O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O O O O O O O O O O O B-Disease I-Disease O O O O 
345,Systematic analysis of coproporphyrinogen oxidase gene defects in hereditary coproporphyria and mutation update .,Systematic analysis of coproporphyrinogen oxidase gene defects in  [ hereditary coproporphyria | Disease ] and mutation update. ,O O O O O O O O B-Disease I-Disease O O O O 
346,Hereditary coproporphyria ( HC ) is an acute hepatic porphyria with autosomal dominant inheritance caused by deficient activity of coproporphyrinogen III oxidase ( CPO ) ., [ Hereditary coproporphyria | Disease ] ( [ HC | Disease ] ) is an acute  [ hepatic porphyria | Disease ] with autosomal dominant inheritance caused by      [ deficient activity of coproporphyrinogen III oxidase | Disease ] ( CPO ). ,B-Disease I-Disease O B-Disease O O O O B-Disease I-Disease O O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O O O O 
347,"Clinical manifestations of the disease are characterized by acute attacks of neurological dysfunction often precipitated by drugs , fasting , cyclical hormonal changes , or infectious diseases .","Clinical manifestations of the disease are characterized by acute attacks of  [ neurological dysfunction | Disease ] often precipitated by drugs, fasting, cyclical hormonal changes, or  [ infectious diseases | Disease ]. ",O O O O O O O O O O O B-Disease I-Disease O O O O O O O O O O O O B-Disease I-Disease O 
348,Skin photosensitivity may also be present .,Skin photosensitivity may also be present. ,O O O O O O O 
349,"The seven exons , the exon / intron boundaries and part of 3 noncoding sequence of the CPO gene were systematically analyzed by an exon - by - exon denaturing gradient gel electrophoresis ( DGGE ) strategy followed by direct sequencing in seven unrelated heterozygous HC patients from France , Holland , and Czech Republic .","The seven exons, the exon / intron boundaries and part of 3 noncoding sequence of the CPO gene were systematically analyzed by an exon - by - exon denaturing gradient gel electrophoresis ( DGGE ) strategy followed by direct sequencing in seven unrelated heterozygous [ HC | Disease ] patients from France, Holland, and Czech Republic. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease O O O O O O O O O O 
350,Seven novel mutations and two new polymorphisms were detected .,Seven novel mutations and two new polymorphisms were detected. ,O O O O O O O O O O 
351,"Among these mutations two are missense ( G197W , W427R ) , two are nonsense ( Q306X , Q385X ) , two are small deletions ( 662de14bp ; 1168del3bp removing a glycine at position 390 ) , and one is a splicing mutation ( IVS1 - 15c - - > g ) which creates a new acceptor splice site .","Among these mutations two are missense ( G197W, W427R ), two are nonsense ( Q306X, Q385X ), two are small deletions ( 662de14bp ; 1168del3bp removing a glycine at position 390 ), and one is a splicing mutation ( IVS1 - 15c - - > g ) which creates a new acceptor splice site. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
352,"The pathological significance of the point mutations G197W , W427R , and the in - frame deletion 390delGly were assessed by their respective expression in a prokaryotic system using site - directed mutagenesis .","The pathological significance of the point mutations G197W, W427R, and the in - frame deletion 390delGly were assessed by their respective expression in a prokaryotic system using site - directed mutagenesis. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
353,These mutations resulted in the absence or a dramatic decrease of CPO activity .,These mutations resulted in the absence or a dramatic decrease of CPO activity. ,O O O O O O O O O O O O O O 
354,"The two polymorphisms were localized in noncoding part of the gene 1 ) a C / G polymorphism in the promotor region , 142 bp upstream from the transcriptional initiation site ( - 142C / G ) , and 2 ) a 6 bp deletion polymorphism in the 3 noncoding part of the CPO gene , 574 bp downstream of the last base of the normal termination codon ( + 574 delATTCTT ) .","The two polymorphisms were localized in noncoding part of the gene 1 ) a C / G polymorphism in the promotor region, 142 bp upstream from the transcriptional initiation site ( - 142C / G ), and 2 ) a 6 bp deletion polymorphism in the 3 noncoding part of the CPO gene, 574 bp downstream of the last base of the normal termination codon ( + 574 delATTCTT ). ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
355,Five intragenic dimorphisms are now well characterized and the high degree of allelic heterogeneity in HC is demonstrated with seven new different mutations making a total of nineteen CPO gene defects reported so far . .,Five intragenic dimorphisms are now well characterized and the high degree of allelic heterogeneity in [ HC | Disease ] is demonstrated with seven new different mutations making a total of nineteen CPO  [ gene defects | Disease ] reported so far.. ,O O O O O O O O O O O O O O O B-Disease O O O O O O O O O O O O O B-Disease I-Disease O O O O O 
356,Coincidence of two novel arylsulfatase A alleles and mutation 459 + 1G > A within a family with metachromatic leukodystrophy : molecular basis of phenotypic heterogeneity .,Coincidence of two novel arylsulfatase A alleles and mutation 459 + 1G > A within a family with  [ metachromatic leukodystrophy | Disease ] : molecular basis of phenotypic heterogeneity. ,O O O O O O O O O O O O O O O O O O B-Disease I-Disease O O O O O O O 
357,"In a family with three siblings , one developed classical late infantile metachromatic leukodystrophy ( MLD ) , fatal at age 5 years , with deficient arylsulfatase A ( ARSA ) activity and increased galactosylsulfatide ( GS ) excretion .","In a family with three siblings, one developed classical late infantile  [ metachromatic leukodystrophy | Disease ] ( [ MLD | Disease ] ), fatal at age 5 years, with deficient arylsulfatase A ( ARSA ) activity and increased galactosylsulfatide ( GS ) excretion. ",O O O O O O O O O O O O B-Disease I-Disease O B-Disease O O O O O O O O O O O O O O O O O O O O O O O O 
358,"The two other siblings , apparently healthy at 12 ( 1 / 2 ) and 15 years , respectively , and their father , apparently healthy as well , presented ARSA and GS values within the range of MLD patients .","The two other siblings, apparently healthy at 12 ( 1 / 2 ) and 15 years, respectively, and their father, apparently healthy as well, presented ARSA and GS values within the range of [ MLD | Disease ] patients. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease O O 
359,Mutation screening and sequence analysis disclosed the involvement of three different ARSA mutations being the molecular basis of intrafamilial phenotypic heterogeneity .,Mutation screening and sequence analysis disclosed the involvement of three different ARSA mutations being the molecular basis of intrafamilial phenotypic heterogeneity. ,O O O O O O O O O O O O O O O O O O O O O O 
360,"The late infantile patient inherited from his mother the frequent 0 - type mutation 459 + 1G > A , and from his father a novel , single basepair microdeletion of guanine at nucleotide 7 in exon 1 ( 7delG ) .","The late infantile patient inherited from his mother the frequent 0 - type mutation 459 + 1G > A, and from his father a novel, single basepair microdeletion of guanine at nucleotide 7 in exon 1 ( 7delG ). ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
361,"The two clinically unaffected siblings carried the maternal mutation 459 + 1G > A and , on their paternal allele , a novel cytosine to thymidine transition at nucleotide 2435 in exon 8 , resulting in substitution of alanine 464 by valine ( A464V ) .","The two clinically unaffected siblings carried the maternal mutation 459 + 1G > A and, on their paternal allele, a novel cytosine to thymidine transition at nucleotide 2435 in exon 8, resulting in substitution of alanine 464 by valine ( A464V ). ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
362,The fathers genotype thus was 7delG / A464V .,The fathers genotype thus was 7delG / A464V. ,O O O O O O O O O 
363,Mutation A464V was not found in 18 unrelated MLD patients and 50 controls .,Mutation A464V was not found in 18 unrelated [ MLD | Disease ] patients and 50 controls. ,O O O O O O O O B-Disease O O O O O 
364,"A464V , although clearly modifying ARSA and GS levels , apparently bears little significance for clinical manifestation of MLD , mimicking the frequent ARSA pseudodeficiency allele .","A464V, although clearly modifying ARSA and GS levels, apparently bears little significance for clinical manifestation of [ MLD | Disease ], mimicking the frequent ARSA pseudodeficiency allele. ",O O O O O O O O O O O O O O O O O O B-Disease O O O O O O O O 
365,"Our results demonstrate that in certain genetic conditions MLD - like ARSA and GS values need not be paralleled by clinical disease , a finding with serious diagnostic and prognostic implications .","Our results demonstrate that in certain genetic conditions [ MLD | Disease ] - like ARSA and GS values need not be paralleled by clinical disease, a finding with serious diagnostic and prognostic implications. ",O O O O O O O O B-Disease O O O O O O O O O O O O O O O O O O O O O O O 
366,"Moreover , further ARSA alleles functionally similar to A464V might exist which , together with 0 - type mutations , may cause pathological ARSA and GS levels , but not clinical outbreak of the disease . .","Moreover, further ARSA alleles functionally similar to A464V might exist which, together with 0 - type mutations, may cause pathological ARSA and GS levels, but not clinical outbreak of the disease.. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
367,Human MLH1 deficiency predisposes to hematological malignancy and neurofibromatosis type 1 .,Human MLH1 deficiency predisposes to  [ hematological malignancy | Disease ] and   [ neurofibromatosis type 1 | Disease ]. ,O O O O O B-Disease I-Disease O B-Disease I-Disease I-Disease O 
368,Heterozygous germ - line mutations in the DNA mismatch repair genes lead to hereditary nonpolyposis colorectal cancer .,Heterozygous germ - line mutations in the DNA mismatch repair genes lead to    [ hereditary nonpolyposis colorectal cancer | Disease ]. ,O O O O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease O 
369,The disease susceptibility of individuals who constitutionally lack both wild - type alleles is unknown .,The disease susceptibility of individuals who constitutionally lack both wild - type alleles is unknown. ,O O O O O O O O O O O O O O O O 
370,"We have identified three offspring in a hereditary nonpolyposis colorectal cancer family who developed hematological malignancy at a very early age , and at least two of them displayed signs of neurofibromatosis type 1 ( NF1 ) .","We have identified three offspring in a    [ hereditary nonpolyposis colorectal cancer | Disease ] family who developed  [ hematological malignancy | Disease ] at a very early age, and at least two of them displayed signs of   [ neurofibromatosis type 1 | Disease ] ( [ NF1 | Disease ] ). ",O O O O O O O B-Disease I-Disease I-Disease I-Disease O O O B-Disease I-Disease O O O O O O O O O O O O O O O B-Disease I-Disease I-Disease O B-Disease O O 
371,DNA sequence analysis and allele - specific amplification in two siblings revealed a homozygous MLH1 mutation ( C676T - - > Arg226Stop ) .,DNA sequence analysis and allele - specific amplification in two siblings revealed a homozygous MLH1 mutation ( C676T - - > Arg226Stop ). ,O O O O O O O O O O O O O O O O O O O O O O O O 
372,"Thus , a homozygous germ - line MLH1 mutation and consequent mismatch repair deficiency results in a mutator phenotype characterized by leukemia and / or lymphoma associated with neurofibromatosis type 1 . .","Thus, a homozygous germ - line MLH1 mutation and consequent mismatch repair deficiency results in a mutator phenotype characterized by [ leukemia | Disease ] and / or [ lymphoma | Disease ] associated with   [ neurofibromatosis type 1 | Disease ].. ",O O O O O O O O O O O O O O O O O O O O O B-Disease O O O B-Disease O O B-Disease I-Disease I-Disease O O 
373,Missense mutations in the most ancient residues of the PAX6 paired domain underlie a spectrum of human congenital eye malformations .,Missense mutations in the most ancient residues of the PAX6 paired domain underlie a spectrum of human   [ congenital eye malformations | Disease ]. ,O O O O O O O O O O O O O O O O O B-Disease I-Disease I-Disease O 
374,"Mutations of the human PAX6 gene underlie aniridia ( congenital absence of the iris ) , a rare dominant malformation of the eye .","Mutations of the human PAX6 gene underlie [ aniridia | Disease ] (     [ congenital absence of the iris | Disease ] ), a rare dominant    [ malformation of the eye | Disease ]. ",O O O O O O O B-Disease O B-Disease I-Disease I-Disease I-Disease I-Disease O O O O O B-Disease I-Disease I-Disease I-Disease O 
375,"The spectrum of PAX6 mutations in aniridia patients is highly biased , with 92 % of all reported mutations leading to premature truncation of the protein ( nonsense , splicing , insertions and deletions ) and just 2 % leading to substitution of one amino acid by another ( missense ) .","The spectrum of PAX6 mutations in [ aniridia | Disease ] patients is highly biased, with 92 % of all reported mutations leading to premature truncation of the protein ( nonsense, splicing, insertions and deletions ) and just 2 % leading to substitution of one amino acid by another ( missense ). ",O O O O O O B-Disease O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
376,The extraordinary conservation of the PAX6 protein at the amino acid level amongst vertebrates predicts that pathological missense mutations should in fact be common even though they are hardly ever seen in aniridia patients .,The extraordinary conservation of the PAX6 protein at the amino acid level amongst vertebrates predicts that pathological missense mutations should in fact be common even though they are hardly ever seen in [ aniridia | Disease ] patients. ,O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease O O 
377,This indicates that there is a heavy ascertainment bias in the selection of patients for PAX6 mutation analysis and that the missing PAX6 missense mutations frequently may underlie phenotypes distinct from textbook aniridia .,This indicates that there is a heavy ascertainment bias in the selection of patients for PAX6 mutation analysis and that the missing PAX6 missense mutations frequently may underlie phenotypes distinct from textbook [ aniridia | Disease ]. ,O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease O 
378,"Here we present four novel PAX6 missense mutations , two in association with atypical phenotypes ectopia pupillae ( displaced pupils ) and congenital nystagmus ( searching gaze ) , and two in association with more recognizable aniridia phenotypes .","Here we present four novel PAX6 missense mutations, two in association with atypical phenotypes  [ ectopia pupillae | Disease ] (  [ displaced pupils | Disease ] ) and  [ congenital nystagmus | Disease ] (  [ searching gaze | Disease ] ), and two in association with more recognizable [ aniridia | Disease ] phenotypes. ",O O O O O O O O O O O O O O O B-Disease I-Disease O B-Disease I-Disease O O B-Disease I-Disease O B-Disease I-Disease O O O O O O O O O B-Disease O O 
379,"Strikingly , all four mutations are located within the PAX6 paired domain and affect amino acids which are highly conserved in all known paired domain proteins .","Strikingly, all four mutations are located within the PAX6 paired domain and affect amino acids which are highly conserved in all known paired domain proteins. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O 
380,Our results support the hypothesis that the under - representation of missense mutations is caused by ascertainment bias and suggest that a substantial burden of PAX6 - related disease remains to be uncovered . .,Our results support the hypothesis that the under - representation of missense mutations is caused by ascertainment bias and suggest that a substantial burden of    [ PAX6 - related disease | Disease ] remains to be uncovered.. ,O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease O O O O O O 
381,"The chromosomal order of genes controlling the major histocompatibility complex , properdin factor B , and deficiency of the second component of complement .","The chromosomal order of genes controlling the major histocompatibility complex, properdin factor B, and       [ deficiency of the second component of complement | Disease ]. ",O O O O O O O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O 
382,The relationship of the genes coding for HLA to those coding for properdin Factor B allotypes and for deficiency of the second component of complement ( C2 ) was studied in families of patients with connective tissue disorders .,The relationship of the genes coding for HLA to those coding for properdin Factor B allotypes and for       [ deficiency of the second component of complement | Disease ] ( C2 ) was studied in families of patients with connective tissue disorders. ,O O O O O O O O O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O O O O O O O O O O O O O O 
383,Patients were selected because they were heterozygous or homozygous for C2 deficiency .,Patients were selected because they were heterozygous or homozygous for  [ C2 deficiency | Disease ]. ,O O O O O O O O O O B-Disease I-Disease O 
384,12 families with 15 matings informative for C2 deficiency were found .,12 families with 15 matings informative for  [ C2 deficiency | Disease ] were found. ,O O O O O O O B-Disease I-Disease O O O 
385,"Of 57 informative meioses , two crossovers were noted between the C2 deficiency gene and the HLA - B gene , with a recombinant fraction of 0 .","Of 57 informative meioses, two crossovers were noted between the  [ C2 deficiency | Disease ] gene and the HLA - B gene, with a recombinant fraction of 0. ",O O O O O O O O O O O B-Disease I-Disease O O O O O O O O O O O O O O O 
386,035 .,035. ,O O 
387,A lod score of 13 was calculated for linkage between C2 deficiency and HLA - B at a maximum likelihood value of the recombinant fraction of 0 .,A lod score of 13 was calculated for linkage between  [ C2 deficiency | Disease ] and HLA - B at a maximum likelihood value of the recombinant fraction of 0. ,O O O O O O O O O O B-Disease I-Disease O O O O O O O O O O O O O O O O 
388,04 .,04. ,O O 
389,18 families with 21 informative matings for both properdin Factor B allotype and HLA - B were found .,18 families with 21 informative matings for both properdin Factor B allotype and HLA - B were found. ,O O O O O O O O O O O O O O O O O O O 
390,"Of 72 informative meioses , three recombinants were found , giving a recombinant fraction of 0 .","Of 72 informative meioses, three recombinants were found, giving a recombinant fraction of 0. ",O O O O O O O O O O O O O O O O O 
391,042 .,042. ,O O 
392,A lod score of 16 between HLA - B and Factor B allotypes was calculated at a maximum likelihood value of the recombinant fraction of 0 .,A lod score of 16 between HLA - B and Factor B allotypes was calculated at a maximum likelihood value of the recombinant fraction of 0. ,O O O O O O O O O O O O O O O O O O O O O O O O O O O 
393,04 .,04. ,O O 
394,"A crossover was shown to have occurred between genes for Factor B and HLA - D , in which HLA - D segregared with HLA - A and B .","A crossover was shown to have occurred between genes for Factor B and HLA - D, in which HLA - D segregared with HLA - A and B. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
395,"These studies suggest that the genes for Factor B and C2 deficiency are located outside those for HLA , that the order of genese is HLA - A , - B , - D , Factor B allotype , C2 deficiency , that the genes coding for C2 deficiency and Factor B allotypes are approximately 3 - - 5 centimorgans from the HLA - A and HLA - B loci , and that the apparent lack of recombinants between the Factor B gene and C2 deficiency gene suggests that these two genes lie in close proximity to one another .","These studies suggest that the genes for Factor B and  [ C2 deficiency | Disease ] are located outside those for HLA, that the order of genese is HLA - A, - B, - D, Factor B allotype,  [ C2 deficiency | Disease ], that the genes coding for  [ C2 deficiency | Disease ] and Factor B allotypes are approximately 3 - - 5 centimorgans from the HLA - A and HLA - B loci, and that the apparent lack of recombinants between the Factor B gene and  [ C2 deficiency | Disease ] gene suggests that these two genes lie in close proximity to one another. ",O O O O O O O O O O B-Disease I-Disease O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease I-Disease O O O O O O B-Disease I-Disease O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease I-Disease O O O O O O O O O O O O O O 
396,Distribution of emerin and lamins in the heart and implications for Emery - Dreifuss muscular dystrophy .,Distribution of emerin and lamins in the heart and implications for     [ Emery - Dreifuss muscular dystrophy | Disease ]. ,O O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease O 
397,Emerin is a nuclear membrane protein which is missing or defective in Emery - Dreifuss muscular dystrophy ( EDMD ) .,Emerin is a nuclear membrane protein which is missing or defective in     [ Emery - Dreifuss muscular dystrophy | Disease ] ( [ EDMD | Disease ] ). ,O O O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease O B-Disease O O 
398,"It is one member of a family of lamina - associated proteins which includes LAP1 , LAP2 and lamin B receptor ( LBR ) .","It is one member of a family of lamina - associated proteins which includes LAP1, LAP2 and lamin B receptor ( LBR ). ",O O O O O O O O O O O O O O O O O O O O O O O O O 
399,A panel of 16 monoclonal antibodies ( mAbs ) has been mapped to six specific sites throughout the emerin molecule using phage - displayed peptide libraries and has been used to localize emerin in human and rabbit heart .,A panel of 16 monoclonal antibodies ( mAbs ) has been mapped to six specific sites throughout the emerin molecule using phage - displayed peptide libraries and has been used to localize emerin in human and rabbit heart. ,O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
400,"Several mAbs against different emerin epitopes did not recognize intercalated discs in the heart , though they recognized cardiomyocyte nuclei strongly , both at the rim and in intranuclear spots or channels .","Several mAbs against different emerin epitopes did not recognize intercalated discs in the heart, though they recognized cardiomyocyte nuclei strongly, both at the rim and in intranuclear spots or channels. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
401,"A polyclonal rabbit antiserum against emerin did recognize both nuclear membrane and intercalated discs but , after affinity purification against a pure - emerin band on a western blot , it stained only the nuclear membrane .","A polyclonal rabbit antiserum against emerin did recognize both nuclear membrane and intercalated discs but, after affinity purification against a pure - emerin band on a western blot, it stained only the nuclear membrane. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
402,"These results would not be expected if immunostaining at intercalated discs were due to a product of the emerin gene and , therefore , cast some doubt upon the hypothesis that cardiac defects in EDMD are caused by absence of emerin from intercalated discs .","These results would not be expected if immunostaining at intercalated discs were due to a product of the emerin gene and, therefore, cast some doubt upon the hypothesis that  [ cardiac defects | Disease ] in [ EDMD | Disease ] are caused by absence of emerin from intercalated discs. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease I-Disease O B-Disease O O O O O O O O O O 
403,"Although emerin was abundant in the membranes of cardiomyocyte nuclei , it was absent from many non - myocyte cells in the heart .","Although emerin was abundant in the membranes of cardiomyocyte nuclei, it was absent from many non - myocyte cells in the heart. ",O O O O O O O O O O O O O O O O O O O O O O O O 
404,"This distribution of emerin was similar to that of lamin A , a candidate gene for an autosomal form of EDMD .","This distribution of emerin was similar to that of lamin A, a candidate gene for an autosomal form of [ EDMD | Disease ]. ",O O O O O O O O O O O O O O O O O O O O B-Disease O 
405,"In contrast , lamin B1 was absent from cardiomyocyte nuclei , showing that lamin B1 is not essential for localization of emerin to the nuclear lamina .","In contrast, lamin B1 was absent from cardiomyocyte nuclei, showing that lamin B1 is not essential for localization of emerin to the nuclear lamina. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O 
406,Lamin B1 is also almost completely absent from skeletal muscle nuclei .,Lamin B1 is also almost completely absent from skeletal muscle nuclei. ,O O O O O O O O O O O O 
407,"In EDMD , the additional absence of lamin B1 from heart and skeletal muscle nuclei which already lack emerin may offer an alternative explanation of why these tissues are particularly affected . .","In [ EDMD | Disease ], the additional absence of lamin B1 from heart and skeletal muscle nuclei which already lack emerin may offer an alternative explanation of why these tissues are particularly affected.. ",O B-Disease O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
408,"Genetic mapping of the copper toxicosis locus in Bedlington terriers to dog chromosome 10 , in a region syntenic to human chromosome region 2p13 - p16 .","Genetic mapping of the  [ copper toxicosis | Disease ] locus in Bedlington terriers to dog chromosome 10, in a region syntenic to human chromosome region 2p13 - p16. ",O O O O B-Disease I-Disease O O O O O O O O O O O O O O O O O O O O O 
409,"Abnormal hepatic copper accumulation is recognized as an inherited disorder in man , mouse , rat and dog .","Abnormal   [ hepatic copper accumulation | Disease ] is recognized as an  [ inherited disorder | Disease ] in man, mouse, rat and dog. ",O B-Disease I-Disease I-Disease O O O O B-Disease I-Disease O O O O O O O O O 
410,"The major cause of hepatic copper accumulation in man is a dysfunctional ATP7B gene , causing Wilson disease ( WD ) .","The major cause of   [ hepatic copper accumulation | Disease ] in man is a dysfunctional ATP7B gene, causing  [ Wilson disease | Disease ] ( [ WD | Disease ] ). ",O O O O B-Disease I-Disease I-Disease O O O O O O O O O B-Disease I-Disease O B-Disease O O 
411,Mutations in the ATP7B genes have also been demonstrated in mouse and rat .,Mutations in the ATP7B genes have also been demonstrated in mouse and rat. ,O O O O O O O O O O O O O O 
412,"The ATP7B gene has been excluded in the much rarer human copper overload disease non - Indian childhood cirrhosis , indicating genetic heterogeneity .","The ATP7B gene has been excluded in the much rarer human  [ copper overload | Disease ] disease     [ non - Indian childhood cirrhosis | Disease ], indicating genetic heterogeneity. ",O O O O O O O O O O O B-Disease I-Disease O B-Disease I-Disease I-Disease I-Disease I-Disease O O O O O 
413,"By investigating the common autosomal recessive copper toxicosis ( CT ) in Bedlington terriers , we have identified a new locus involved in progressive liver disease .","By investigating the common autosomal recessive  [ copper toxicosis | Disease ] ( [ CT | Disease ] ) in Bedlington terriers, we have identified a new locus involved in progressive  [ liver disease | Disease ]. ",O O O O O O B-Disease I-Disease O B-Disease O O O O O O O O O O O O O O B-Disease I-Disease O 
414,"We examined whether the WD gene ATP7B was also causative for CT by investigating the chromosomal co - localization of ATP7B and C04107 , using fluorescence in situ hybridization ( FISH ) .","We examined whether the [ WD | Disease ] gene ATP7B was also causative for [ CT | Disease ] by investigating the chromosomal co - localization of ATP7B and C04107, using fluorescence in situ hybridization ( FISH ). ",O O O O B-Disease O O O O O O B-Disease O O O O O O O O O O O O O O O O O O O O O 
415,C04107 is an anonymous microsatellite marker closely linked to CT .,C04107 is an anonymous microsatellite marker closely linked to [ CT | Disease ]. ,O O O O O O O O O B-Disease O 
416,"However , BAC clones containing ATP7B and C04107 mapped to the canine chromosome regions CFA22q11 and CFA10q26 , respectively , demonstrating that WD cannot be homologous to CT .","However, BAC clones containing ATP7B and C04107 mapped to the canine chromosome regions CFA22q11 and CFA10q26, respectively, demonstrating that [ WD | Disease ] cannot be homologous to [ CT | Disease ]. ",O O O O O O O O O O O O O O O O O O O O O O B-Disease O O O O B-Disease O 
417,The copper transport genes CTR1 and CTR2 were also excluded as candidate genes for CT since they both mapped to canine chromosome region CFA11q22 .,The copper transport genes CTR1 and CTR2 were also excluded as candidate genes for [ CT | Disease ] since they both mapped to canine chromosome region CFA11q22. ,O O O O O O O O O O O O O O B-Disease O O O O O O O O O O 
418,2 - 22 .,2 - 22. ,O O O O 
419,5 .,5. ,O O 
420,"A transcribed sequence identified from the C04107 - containing BAC was found to be homologous to a gene expressed from human chromosome 2p13 - p16 , a region devoid of any positional candidate genes .","A transcribed sequence identified from the C04107 - containing BAC was found to be homologous to a gene expressed from human chromosome 2p13 - p16, a region devoid of any positional candidate genes. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
421,Molecular analysis of the APC gene in 205 families : extended genotype - phenotype correlations in FAP and evidence for the role of APC amino acid changes in colorectal cancer predisposition .,Molecular analysis of the [ APC | Disease ] gene in 205 families : extended genotype - phenotype correlations in [ FAP | Disease ] and evidence for the role of [ APC | Disease ] amino acid changes in  [ colorectal cancer | Disease ] predisposition. ,O O O O B-Disease O O O O O O O O O O O B-Disease O O O O O O B-Disease O O O O B-Disease I-Disease O O 
422,BACKGROUND / AIMS The development of colorectal cancer and a variable range of extracolonic manifestations in familial adenomatous polyposis ( FAP ) is the result of the dominant inheritance of adenomatous polyposis coli ( APC ) gene mutations .,BACKGROUND / AIMS The development of  [ colorectal cancer | Disease ] and a variable range of extracolonic manifestations in   [ familial adenomatous polyposis | Disease ] ( [ FAP | Disease ] ) is the result of the dominant inheritance of   [ adenomatous polyposis coli | Disease ] ( [ APC | Disease ] ) gene mutations. ,O O O O O O B-Disease I-Disease O O O O O O O O B-Disease I-Disease I-Disease O B-Disease O O O O O O O O O B-Disease I-Disease I-Disease O B-Disease O O O O 
423,"In this study , direct mutation analysis of the APC gene was performed to determine genotype - phenotype correlations for nine extracolonic manifestations and to investigate the incidence of APC mutations in non - FAP colorectal cancer .","In this study, direct mutation analysis of the [ APC | Disease ] gene was performed to determine genotype - phenotype correlations for nine extracolonic manifestations and to investigate the incidence of [ APC | Disease ] mutations in non - FAP  [ colorectal cancer | Disease ]. ",O O O O O O O O O B-Disease O O O O O O O O O O O O O O O O O O O B-Disease O O O O O B-Disease I-Disease O 
424,"METHODS The APC gene was analysed in 190 unrelated FAP and 15 non - FAP colorectal cancer patients using denaturing gradient gel electrophoresis , the protein truncation test , and direct sequencing .","METHODS The [ APC | Disease ] gene was analysed in 190 unrelated [ FAP | Disease ] and 15 non - FAP  [ colorectal cancer | Disease ] patients using denaturing gradient gel electrophoresis, the protein truncation test, and direct sequencing. ",O O B-Disease O O O O O O B-Disease O O O O O B-Disease I-Disease O O O O O O O O O O O O O O O O 
425,RESULTS Chain terminating signals were only identified in patients belonging to the FAP group ( 105 patients ) .,RESULTS Chain terminating signals were only identified in patients belonging to the [ FAP | Disease ] group ( 105 patients ). ,O O O O O O O O O O O O B-Disease O O O O O O 
426,"Amino acid changes were identified in four patients , three of whom belonged to the non - FAP group of colorectal cancer patients .","Amino acid changes were identified in four patients, three of whom belonged to the non - FAP group of  [ colorectal cancer | Disease ] patients. ",O O O O O O O O O O O O O O O O O O O O B-Disease I-Disease O O 
427,Genotype - phenotype correlations identified significant differences in the nature of certain extracolonic manifestations in FAP patients belonging to three mutation subgroups .,Genotype - phenotype correlations identified significant differences in the nature of certain extracolonic manifestations in [ FAP | Disease ] patients belonging to three mutation subgroups. ,O O O O O O O O O O O O O O O B-Disease O O O O O O O 
428,CONCLUSIONS Extended genotype - phenotype correlations made in this study may have the potential to determine the most appropriate surveillance and prophylactic treatment regimens for those patients with mutations associated with life threatening conditions .,CONCLUSIONS Extended genotype - phenotype correlations made in this study may have the potential to determine the most appropriate surveillance and prophylactic treatment regimens for those patients with mutations associated with life threatening conditions. ,O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
429,This study also provided evidence for the pathological nature of amino acid changes in APC associated with both FAP and non - FAP colorectal cancer patients . .,This study also provided evidence for the pathological nature of amino acid changes in APC associated with both [ FAP | Disease ] and non - FAP  [ colorectal cancer | Disease ] patients.. ,O O O O O O O O O O O O O O O O O O B-Disease O O O O B-Disease I-Disease O O O 
430,Inherited colorectal polyposis and cancer risk of the APC I1307K polymorphism .,  [ Inherited colorectal polyposis | Disease ] and [ cancer | Disease ] risk of the APC I1307K polymorphism. ,B-Disease I-Disease I-Disease O B-Disease O O O O O O O 
431,"Germ - line and somatic truncating mutations of the APC gene are thought to initiate colorectal tumor formation in familial adenomatous polyposis syndrome and sporadic colorectal carcinogenesis , respectively .","Germ - line and somatic truncating mutations of the [ APC | Disease ] gene are thought to initiate  [ colorectal tumor | Disease ] formation in    [ familial adenomatous polyposis syndrome | Disease ] and sporadic colorectal carcinogenesis, respectively. ",O O O O O O O O O B-Disease O O O O O B-Disease I-Disease O O B-Disease I-Disease I-Disease I-Disease O O O O O O O 
432,"Recently , an isoleucine - - > lysine polymorphism at codon 1307 ( I1307K ) of the APC gene has been identified in 6 % - 7 % of the Ashkenazi Jewish population .","Recently, an isoleucine - - > lysine polymorphism at codon 1307 ( I1307K ) of the [ APC | Disease ] gene has been identified in 6 % - 7 % of the Ashkenazi Jewish population. ",O O O O O O O O O O O O O O O O O B-Disease O O O O O O O O O O O O O O O O 
433,"To assess the risk of this common APC allelic variant in colorectal carcinogenesis , we have analyzed a large cohort of unselected Ashkenazi Jewish subjects with adenomatous polyps and . or colorectal cancer , for the APC I1307K polymorphism .","To assess the risk of this common [ APC | Disease ] allelic variant in colorectal carcinogenesis, we have analyzed a large cohort of unselected Ashkenazi Jewish subjects with  [ adenomatous polyps | Disease ] and. or   [ colorectal cancer , | Disease ] for the APC I1307K polymorphism. ",O O O O O O O B-Disease O O O O O O O O O O O O O O O O O O B-Disease I-Disease O O O B-Disease I-Disease I-Disease O O O O O O 
434,The APC I1307K allele was identified in 48 ( 10 . 1 % ) of 476 patients .,The APC I1307K allele was identified in 48 ( 10. 1 % ) of 476 patients. ,O O O O O O O O O O O O O O O O O O 
435,"Compared with the frequency in two separate population control groups , the APC I1307K allele is associated with an estimated relative risk of 1 .","Compared with the frequency in two separate population control groups, the APC I1307K allele is associated with an estimated relative risk of 1. ",O O O O O O O O O O O O O O O O O O O O O O O O O 
436,5 - 1 .,5 - 1. ,O O O O 
437,7 for colorectal neoplasia ( both P = . 01 ) .,7 for  [ colorectal neoplasia | Disease ] ( both P =. 01 ). ,O O B-Disease I-Disease O O O O O O O O 
438,"Furthermore , compared with noncarriers , APC I1307K carriers had increased numbers of adenomas and colorectal cancers per patient ( P = . 03 ) , as well as a younger age at diagnosis .","Furthermore, compared with noncarriers, APC I1307K carriers had increased numbers of [ adenomas | Disease ] and  [ colorectal cancers | Disease ] per patient ( P =. 03 ), as well as a younger age at diagnosis. ",O O O O O O O O O O O O O B-Disease O B-Disease I-Disease O O O O O O O O O O O O O O O O O O 
439,We conclude that the APC I1307K variant leads to increased adenoma formation and directly contributes to 3 % - 4 % of all Ashkenazi Jewish colorectal cancer .,We conclude that the APC I1307K variant leads to increased [ adenoma | Disease ] formation and directly contributes to 3 % - 4 % of all Ashkenazi Jewish  [ colorectal cancer | Disease ]. ,O O O O O O O O O O B-Disease O O O O O O O O O O O O O O B-Disease I-Disease O 
440,"The estimated relative risk for carriers may justify specific clinical screening for the 360 , 000 Americans expected to harbor this allele , and genetic testing in the setting of long - term - outcome studies may impact significantly on colorectal cancer prevention in this population .","The estimated relative risk for carriers may justify specific clinical screening for the 360, 000 Americans expected to harbor this allele, and genetic testing in the setting of long - term - outcome studies may impact significantly on  [ colorectal cancer | Disease ] prevention in this population. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O B-Disease I-Disease O O O O O 
441,"Localization of human BRCA1 and its loss in high - grade , non - inherited breast carcinomas .","Localization of human BRCA1 and its loss in high - grade,     [ non - inherited breast carcinomas | Disease ]. ",O O O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease O 
442,"Although the link between the BRCA1 tumour - suppressor gene and hereditary breast and ovarian cancer is established , the role , if any , of BRCA1 in non - familial cancers is unclear .","Although the link between the BRCA1 [ tumour | Disease ] - suppressor gene and     [ hereditary breast and ovarian cancer | Disease ] is established, the role, if any, of BRCA1 in    [ non - familial cancers | Disease ] is unclear. ",O O O O O O B-Disease O O O O B-Disease I-Disease I-Disease I-Disease I-Disease O O O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease O O O 
443,"BRCA1 mutations are rare in sporadic cancers , but loss of BRCA1 resulting from reduced expression or incorrect subcellular localization is postulated to be important in non - familial breast and ovarian cancers .","BRCA1 mutations are rare in  [ sporadic cancers | Disease ], but loss of BRCA1 resulting from reduced expression or incorrect subcellular localization is postulated to be important in       [ non - familial breast and ovarian cancers | Disease ]. ",O O O O O B-Disease I-Disease O O O O O O O O O O O O O O O O O O O B-Disease I-Disease I-Disease I-Disease I-Disease I-Disease I-Disease O 
444,"Epigenetic loss , however , has not received general acceptance due to controversy regarding the subcellular localization of BRCA1 proteins , reports of which have ranged from exclusively nuclear , to conditionally nuclear , to the ER / golgi , to cytoplasmic invaginations into the nucleus .","Epigenetic loss, however, has not received general acceptance due to controversy regarding the subcellular localization of BRCA1 proteins, reports of which have ranged from exclusively nuclear, to conditionally nuclear, to the ER / golgi, to cytoplasmic invaginations into the nucleus. ",O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O O 
445,"In an attempt to resolve this issue , we have comprehensively characterized 19 anti - BRCA1 antibodies .","In an attempt to resolve this issue, we have comprehensively characterized 19 anti - BRCA1 antibodies. ",O O O O O O O O O O O O O O O O O O 
446,"These reagents detect a 220 - kD protein localized in discrete nuclear foci in all epithelial cell lines , including those derived from breast malignancies .","These reagents detect a 220 - kD protein localized in discrete nuclear foci in all epithelial cell lines, including those derived from  [ breast malignancies | Disease ]. ",O O O O O O O O O O O O O O O O O O O O O O O B-Disease I-Disease O 
447,"Immunohistochemical staining of human breast specimens also revealed BRCA1 nuclear foci in benign breast , invasive lobular cancers and low - grade ductal carcinomas .","Immunohistochemical staining of human breast specimens also revealed BRCA1 nuclear foci in benign breast,   [ invasive lobular cancers | Disease ] and     [ low - grade ductal carcinomas | Disease ]. ",O O O O O O O O O O O O O O O B-Disease I-Disease I-Disease O B-Disease I-Disease I-Disease I-Disease I-Disease O 
448,"Conversely , BRCA1 expression was reduced or undetectable in the majority of high - grade , ductal carcinomas , suggesting that absence of BRCA1 may contribute to the pathogenesis of a significant percentage of sporadic breast cancers . .","Conversely, BRCA1 expression was reduced or undetectable in the majority of high - grade,  [ ductal carcinomas | Disease ], suggesting that absence of BRCA1 may contribute to the pathogenesis of a significant percentage of   [ sporadic breast cancers | Disease ].. ",O O O O O O O O O O O O O O O O B-Disease I-Disease O O O O O O O O O O O O O O O O B-Disease I-Disease I-Disease O O 
